[go: up one dir, main page]

US20180042675A1 - Methods and apparatus for multi-catheter tissue ablation - Google Patents

Methods and apparatus for multi-catheter tissue ablation Download PDF

Info

Publication number
US20180042675A1
US20180042675A1 US15/795,075 US201715795075A US2018042675A1 US 20180042675 A1 US20180042675 A1 US 20180042675A1 US 201715795075 A US201715795075 A US 201715795075A US 2018042675 A1 US2018042675 A1 US 2018042675A1
Authority
US
United States
Prior art keywords
electrodes
anode
electrode
catheter
cathode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/795,075
Inventor
Gary L. Long
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Farapulse Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farapulse Inc filed Critical Farapulse Inc
Priority to US15/795,075 priority Critical patent/US20180042675A1/en
Assigned to IOWA APPROACH, INC. reassignment IOWA APPROACH, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GLL, LLC, LONG, GARY L.
Publication of US20180042675A1 publication Critical patent/US20180042675A1/en
Assigned to FARAPULSE, INC. reassignment FARAPULSE, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: IOWA APPROACH, INC.
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FARAPULSE, INC.
Priority to US17/207,053 priority patent/US12137968B2/en
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FARAPULSE, INC.
Priority to US18/943,623 priority patent/US20250064511A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00137Details of operation mode
    • A61B2017/00154Details of operation mode pulsed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • A61B2018/00363Epicardium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00613Irreversible electroporation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00642Sensing and controlling the application of energy with feedback, i.e. closed loop control
    • A61B2018/00654Sensing and controlling the application of energy with feedback, i.e. closed loop control with individual control of each of a plurality of energy emitting elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00666Sensing and controlling the application of energy using a threshold value
    • A61B2018/00672Sensing and controlling the application of energy using a threshold value lower
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00702Power or energy
    • A61B2018/00708Power or energy switching the power on or off
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00839Bioelectrical parameters, e.g. ECG, EEG
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00875Resistance or impedance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • A61B2018/124Generators therefor switching the output to different electrodes, e.g. sequentially
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • A61B2018/1246Generators therefor characterised by the output polarity
    • A61B2018/126Generators therefor characterised by the output polarity bipolar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • A61B2018/1266Generators therefor with DC current output
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
    • A61N1/3688Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions configured for switching the pacing mode, e.g. from AAI to DDD

Definitions

  • the embodiments described herein relate generally to medical devices for therapeutic electrical energy delivery, and more particularly to systems and methods for delivering electrical energy in the context of ablating tissue rapidly and selectively by the application of suitably timed pulsed voltages that generate irreversible electroporation of cell membranes.
  • the applied electric field at the membrane exceeds a threshold value, typically dependent on cell size, the electroporation is irreversible and the pores remain open, permitting exchange of material across the membrane and leading to apoptosis or cell death. Subsequently, the surrounding tissue heals in a natural process.
  • some known catheters and systems include a single multi-electrode catheter in which certain electrodes receive a voltage signal having a first polarity and other electrodes receive a voltage signal having the opposite polarity. Accordingly, to minimize the risk of dielectric breakdown within the catheter, such known catheters typically include substantial insulation (e.g., around the leads), thus increasing the size and limiting the flexibility of the catheter.
  • Some known catheters configured to produce voltage pulses of up to 5 kV include catheter leads having an insulation of as much as 0.2 mm and an overall size of about 14 French (4.67 mm).
  • an apparatus includes a voltage pulse generator and an electrode controller.
  • the voltage pulse generator is configured to produce a pulsed voltage waveform.
  • the electrode controller is configured to be operably coupled to the voltage pulse generator.
  • the electrode controller includes a first output port and a second output port.
  • the first output port is configured to be operatively coupled to a first medical device including a first set of electrodes
  • the second output port is configured to be operatively coupled to a second medical device including a second set of electrodes.
  • the electrode controller includes a selection module and a pulse delivery module.
  • the selection module is configured to select at least a first electrode from the first set of electrodes and identify at least the first electrode as an anode.
  • the selection module is configured to select at least a second electrode from the second set of electrodes and identify at least the second electrode as a cathode.
  • the pulse delivery module is configured to deliver a first output signal having a first polarity and being associated with the pulsed voltage waveform to the first output port for application to the first electrode.
  • the pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and being associated with the pulsed voltage waveform to the second output port for application to the second electrode.
  • FIG. 1 is a perspective view showing two catheters according to an embodiment, each with multiple electrodes disposed along its shaft and wrapped around a portion of the pulmonary veins and being within the epicardial space of the heart in a subject body such that they form an approximately closed contour around the pulmonary veins.
  • FIG. 2 is a schematic illustration of a catheter according to an embodiment, with a multiplicity of electrodes disposed along its shaft, with an electrical lead attached to the inner side of each electrode, and with a magnet located near the distal end of the catheter.
  • FIG. 3 illustrates two flexible catheter devices with multiple electrodes disposed along their shafts and positioned to wrap around respective approximate halves of a single closed contour around the pulmonary veins in the epicardial space of the heart, with their distal ends positioned in close proximity.
  • FIG. 4 is an illustration of two flexible catheter devices with multiple electrodes disposed along their shafts and positioned to wrap around respective approximate halves of a single closed contour around the pulmonary veins in the epicardial space of the heart, with active electrodes identified according to an embodiment.
  • FIG. 5A is a schematic illustration of an irreversible electroporation system according to an embodiment that includes a voltage/signal generator, a controller capable of being configured to apply voltages to selected subsets of electrodes with independent subset selections for anode electrodes on one medical device and cathode electrodes on a second medical device.
  • FIG. 5B is a schematic illustration of an irreversible electroporation system according to an embodiment that includes a voltage/signal generator, a controller capable of being configured to apply voltages to selected subsets of electrodes with independent subset selections for anode electrodes on one medical device and cathode electrodes on a second medical device.
  • FIG. 6 is an illustration of an ECG waveform showing the refractory periods during atrial and ventricular pacing, and the time windows for irreversible electroporation ablation.
  • FIG. 7 is a schematic illustration of a method of selecting subsets of electrodes on two catheters as anodes or cathodes, according to an embodiment, whereby the ablation vector or predominant current density direction vector is selected for ablation.
  • FIG. 8 is a schematic illustration of a user interface of the present invention, showing electrodes on two catheters, and buttons for selection or marking of anode electrode subsets and cathode electrode subsets.
  • FIG. 9 is a schematic illustration of a user interface according to an embodiment, for selection of anode and cathode electrode subsets, showing a single selected anode electrode on one catheter and two selected cathode electrodes on a second catheter.
  • FIG. 10 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a balanced square wave.
  • FIG. 11 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a balanced biphasic square wave.
  • FIG. 12 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a progressive balanced biphasic square wave.
  • an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with anode and cathode subsets being selected independently on distinct medical devices.
  • the controller is additionally capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence.
  • an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with independent subset selections for anode and cathode electrode selections on distinct catheter devices respectively. Further, the controller is capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence.
  • the generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes.
  • an apparatus in some embodiments, includes a voltage pulse generator and an electrode controller.
  • the voltage pulse generator is configured to produce a pulsed voltage waveform.
  • the electrode controller is configured to be operably coupled to the voltage pulse generator.
  • the electrode controller includes a first output port and a second output port.
  • the first output port is configured to be operatively coupled to a first medical device including a first set of electrodes
  • the second output port is configured to be operatively coupled to a second medical device including a second set of electrodes.
  • the electrode controller includes a selection module and a pulse delivery module.
  • the selection module is configured to select at least a first electrode from the first set of electrodes and identify at least the first electrode as an anode.
  • the selection module is configured to select at least a second electrode from the second set of electrodes and identify at least the second electrode as a cathode.
  • the pulse delivery module is configured to deliver a first output signal having a first polarity and being associated with the pulsed voltage waveform to the first output port for application to the first electrode.
  • the pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and being associated with the pulsed voltage waveform to the second output port for application to the second electrode.
  • an apparatus in some embodiments, includes a voltage pulse generator and an electrode controller.
  • the voltage pulse generator is configured to produce a pulsed voltage waveform.
  • the electrode controller is configured to be operably coupled to the voltage pulse generator.
  • the electrode controller includes a first output port and a second output port, the first output port configured to be operatively coupled to a first medical device including a first set of electrodes, the second output port configured to be operatively coupled to a second medical device including a second set of electrodes.
  • the electrode controller includes a selection module and a pulse delivery module.
  • the selection module is configured to select a set of anode/cathode pairs, each anode selected being only in the first plurality of electrodes, each cathode selected being only in the second plurality of electrodes.
  • the pulse delivery module is configured to deliver a first output signal having a first polarity and associated with the pulsed voltage waveform to the first output port for application to each anode selected.
  • the pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and associated with the pulsed voltage waveform to the second output port for application to each cathode selected.
  • the pulse delivery module is configured to deliver the first output signal and the second output signal to the plurality of anode/cathode pairs according to a sequential pattern.
  • a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs, each anode selected being only in a first set of electrodes of a first multi-electrode catheter, each cathode selected being only in a second set of electrodes of a second multi-electrode catheter.
  • the first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart.
  • a pacing signal is conveyed to a pacing lead configured to be operatively coupled to the heart.
  • the method includes receiving, at a feedback module, an electrocardiograph signal associated with a function of the heart.
  • the method includes delivering, via a pulse delivery module of the electrode controller, a first output signal having a first polarity to each anode selected, and delivering, via the pulse delivery module, a second output signal having a second polarity opposite the first polarity to each cathode selected.
  • the first output signal and the second output signal are delivered according to a sequential pattern.
  • a non-transitory processor readable medium storing code representing instructions to be executed by a processor includes code to cause the processor to identify a set of anode/cathode pairs. Each anode in the plurality of anode/cathode pairs being only in a first set of electrodes of a first multi-electrode catheter. Each cathode in the set of anode/cathode pairs being only in a second set of electrodes of a second multi-electrode catheter.
  • the first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart.
  • the code further includes code to convey a pacing signal to a pacing lead configured to be operatively coupled to the heart, and receive an electrocardiograph signal associated with a function of the heart.
  • the code further includes code to deliver, according to a sequential pattern, a first output signal having a first polarity to each anode selected and a second output signal having a second polarity opposite the first polarity to each cathode selected.
  • system includes a first flexible catheter including a first set of electrodes and a second flexible catheter including a second set of electrodes.
  • a distal end portion of the first flexible catheter is configured to be coupled to a distal end portion of the second catheter to form a continuous length including the first set of electrodes and the second set of electrodes.
  • the first flexible catheter and the second flexible catheter are configured to deliver a bipolar voltage signal to a target tissue such that a first portion of the bipolar voltage signal having a first polarity is delivered only to the first set of electrodes and a second portion of the bipolar voltage signal having second polarity opposite the first polarity is delivered only to the second set of electrodes.
  • a member is intended to mean a single member or a combination of members
  • a material is intended to mean one or more materials
  • a processor is intended to mean a single processor or multiple processors
  • memory is intended to mean one or more memories, or a combination thereof.
  • the terms “about” and “approximately” generally mean plus or minus 10% of the value stated. For example, about 0.5 would include 0.45 and 0.55, about 10 would include 9 to 11, about 1000 would include 900 to 1100.
  • a Pulmonary Vein isolation (PV isolation) system includes two ablation catheter devices, one (labeled 5 ) with distal end 15 and proximal portion 8 , the other (labeled 6 ) with distal end 16 and proximal portion 9 , each with a multiplicity of electrodes (indicated by dark bands such as those marked as 19 ) disposed along its length, and where each catheter is wrapped in the epicardial space around a portion of the pulmonary veins 10 , 11 , 12 and 13 of a heart 7 in a subject or patient anatomy, with the proximal portions 8 and 9 of the respective catheters 5 and 6 extending out and away to eventually emerge from the patient's chest.
  • V isolation Pulmonary Vein isolation
  • the distal ends of the two catheters 5 and 6 have magnets 15 and 16 respectively that can aid in alignment of the two catheters.
  • the ablation catheters 5 and 6 , and any of the catheters described herein can be similar to the ablation catheters described in PCT Publication No. WO2014/025394, entitled “Catheters, Catheter Systems, and Methods for Puncturing Through a Tissue Structure,” filed on Mar. 14, 2013 (“the '394 PCT Application), which is incorporated herein by reference in its entirety.
  • the ablation catheters 5 and 6 can be disposed about the pulmonary veins 10 , 11 , 12 and 13 using any suitable procedure and apparatus.
  • the ablation catheters can be disposed about the pulmonary veins 10 , 11 , 12 and 13 and/or the heart 7 using a puncturing apparatus disposed via a subxiphoid pericardial access location and a using guidewire-based delivery method as described in the '394 PCT Application. Similar methods can be used to deliver and position the two catheters 5 and 6 . After the ends 8 and 9 of the two respective catheters 5 and 6 extend and emerge out of the patient chest they can be cinched together to effectively hold the catheters in place or in stable positions relative to each other.
  • a DC voltage for electroporation can be applied to subsets of electrodes identified as anodes and cathodes respectively on the two catheters on approximately opposite sides of the closed contour defined by the shapes of the catheters 5 and 6 around the pulmonary veins.
  • the DC voltage is applied in brief pulses sufficient to cause irreversible electroporation and can be in the range of 0.5 kV to 10 kV and more preferably in the range 1 kV to 2.5 kV, so that a threshold electric field value of around 200 Volts/cm is effectively achieved in the cardiac tissue to be ablated.
  • the marked or active electrodes on the two catheters can be automatically identified, or manually identified by suitable marking, on an X-ray or fluoroscopic image obtained at an appropriate angulation that permits identification of the geometric distance between anode and cathode electrodes, or their respective centroids.
  • the DC voltage generator setting for irreversible electroporation is then automatically identified by the electroporation system based on this distance measure.
  • the DC voltage value is selected directly by a user from a suitable dial, slider, touch screen, or any other user interface.
  • the DC voltage pulse results in a current flowing between the anode and cathode electrodes on opposite sides of the contour defined by the conjoint shapes of the two catheters, with said current flowing through the cardiac wall tissue and through the intervening blood in the cardiac chamber, with the current entering the cardiac tissue from the anode electrodes and returning back through the cathode electrodes.
  • the forward and return current paths are respectively inside distinct catheters, since all active electrodes on a given catheter are of like polarity. Areas of cardiac wall tissue where the electric field is sufficiently large for irreversible electroporation are ablated during the DC voltage pulse application.
  • FIG. 2 is a schematic illustration of a multi-electrode, magnet-tipped catheter according to an embodiment.
  • the catheter shaft 801 has a multiplicity of electrodes disposed along an extensive length of catheter at least 5 cm in extent.
  • the metallic electrodes could be poly-metallic in construction, for example, including regions of Titanium and regions of Platinum.
  • FIG. 2 shows only four electrodes 803 , 804 , 805 and 806 for clarity, in other embodiments, the number of electrodes can be in the range between 5 and 30, and more preferably in the range between 8 and 18.
  • Each electrode attaches to a corresponding lead, thus as shown in FIG. 2 , electrodes 803 , 804 , 805 and 806 attach to leads 813 , 814 , 815 and 816 , respectively.
  • the catheter shaft is made of a flexible polymeric material such as for example Teflon, Nylon or Pebax.
  • the leads 813 , 814 , 815 and 816 include an insulative covering to ensure that each lead/electrode is electrically isolated from the other leads and electrodes coupled to the catheter shaft 801 .
  • all of the electrodes 803 , 804 , 805 and 806 of the catheter 801 have the same polarity.
  • the need for high dielectric strength material separating the leads is not a significant constraint. Accordingly, the insulative material covering each lead can be minimized, and the catheter can be relatively small in diameter.
  • the catheter device can have a high degree of flexibility to facilitate the method of surrounding the pulmonary veins as described herein.
  • the catheter device can have a size in the range of approximately 9 French (3 mm), 8 French (2.67 mm) or even 6 French (2 mm).
  • the electrode leads of the catheter device can have an insulation thickness of less than about 0.05 mm, less than about 0.01 m, or less than about 0.005 mm. In other embodiments, the electrode leads of the catheter can have an insulation thickness of between about 0.03 mm and about 0.06 mm.
  • the catheter device 801 can enhance the efficacy of irreversible electroporation ablation.
  • the voltage applied to the electrodes 803 , 804 , 805 and 806 can be in the range of 0.5 kV to 2.5 kV; 2.5 kV to 5 kV, and up to 10 kV and more preferably in the range 1 kV to 2.5 kV.
  • the distal end of the catheter 801 has a ring-shaped magnet 809 , with the magnet having a magnetization direction that is substantially aligned with the longitudinal axis of the catheter.
  • the magnet 809 is configured to have a polarity to cooperate with a corresponding magnet from a second catheter to be used in conjunction with the catheter 801 .
  • the magnets 15 and 16 shown respectively at the distal ends of the two catheters 5 and 6 in FIG. 1 have opposite polarities on their distal faces, so that they attract each other. This attraction can aid in approximate alignment and/or coupling of the catheters.
  • anode and cathode electrodes for voltage application can be selected on distinct devices in accordance with the methods described herein.
  • each of the catheters includes fewer electrodes and few leads than if a single catheter were used to surround the heart.
  • the reduction of the number of leads and electrodes also allows for an overall reduction in the size of the catheter, improvement in the flexibility thereof, and the like.
  • a system in some embodiments, for example, includes a first catheter including a first set of electrodes and a second flexible catheter including a second set of electrodes.
  • Each of the catheters can be, for example, the catheter 801 .
  • a distal end portion of the first flexible catheter is configured to be coupled to a distal end portion of the second catheter to form a continuous length including the first set of electrodes and the second set of electrodes.
  • the connection can be via a magnetic coupling device, as shown herein.
  • the first flexible catheter and the second flexible catheter are configured to deliver a bipolar voltage signal to a target tissue such that a first portion of the bipolar voltage signal having a first polarity is delivered only to the first set of electrodes and a second portion of the bipolar voltage signal having second polarity opposite the first polarity is delivered only to the second set of electrodes.
  • FIG. 3 shows another example of the placement of a first catheter 538 and a second catheter 539 , according to an embodiment.
  • the first catheter 538 and the second catheter 539 can each be constructed of a small diameter tube covered by multiple metal electrodes.
  • the distal ends of the catheters ( 544 and 554 respectively) contain magnets that attract and allow for alignment of the devices when their distal ends are in close proximity as indicated by region 545 .
  • Electrodes 543 disposed along the first catheter 538 are of a single polarity (for instance, an activated subset of the electrodes would all be anodes), while electrodes 553 disposed along the second catheter 539 are all of the opposite polarity (in the same example, an activated subset could all be cathodes).
  • Wires are connected to each electrode in the anode and cathode catheters, indicated by collective anode leads 542 and collective cathode leads 552 respectively.
  • wires of opposite polarity are not in the same catheter, thereby reducing the possibility of dielectric breakdown at high voltage, as discussed above.
  • Reduced diameter catheters can be significantly more flexible and a smaller number of leads in a given catheter (resulting in a smaller catheter diameter) can be advantageous in this regard. While in this example the two catheters are navigated and coupled magnetically, those skilled in the art could implement other means of alignment and positioning of the catheters without departing from the scope of the teachings herein.
  • FIG. 4 shows the first catheter 538 and the second catheter 539 having proximal leads 542 and 552 , respectively, and having distal ends 544 and 554 , respectively.
  • the a single active anode electrode 604 is selected on the second catheter 539
  • two active cathode electrodes 601 and 602 are selected on the first catheter 538 .
  • a DC voltage for irreversible electroporation ablation can then be applied across the selected anode-cathode electrodes.
  • FIG. 5A A schematic diagram of an electroporation system according to an embodiment is shown in FIG. 5A .
  • the system includes a DC voltage/signal generator 23 that is driven by a controller unit 21 .
  • the controller unit 21 interfaces with a computer device 24 by means of a two-way communication link 29 .
  • the controller interface can act as a multiplexer unit and perform channel selection and routing functions for applying DC voltages to appropriate electrodes that have been selected by a user or by the computer 24 .
  • the controller can apply the voltages via a multiplicity of leads to a first catheter device 22 , as well as a second catheter device 122 .
  • Active electrodes can be selected on a first catheter device 22 with one polarity, and likewise active electrodes can be selected on a second catheter device 122 with the opposite polarity.
  • one or more leads from the controller 21 could also carry pacing signals to drive pacing of the heart through a separate pacing device (not shown).
  • the catheter devices can also send back information such as ECG recordings or data from other sensors back to the controller 21 , possibly on separate leads.
  • the DC voltage generator 23 sends a DC voltage to the controller 21 through leads 27 , the voltage generator is driven by control and timing inputs 28 from the controller unit 21 .
  • the resulting ECG waveform 32 has appropriate respective refractory time intervals 33 and 34 respectively, during which there are suitable time windows for application of irreversible electroporation as indicated by 35 and 36 .
  • the application of cardiac pacing results in a periodic, well-controlled sequence of electroporation time windows. Typically, this time window is of the order of hundreds of microseconds to about a millisecond or more. During this window, multiple DC voltage pulses can be applied to ensure that sufficient tissue ablation has occurred. The user can repeat the delivery of irreversible electroporation over several successive cardiac cycles for further confidence.
  • a feedback module e.g., feedback module 905
  • a pulse delivery module e.g., pulse delivery module 908
  • a feedback module can receive the electrocardiograph signal
  • a pulse delivery module e.g., pulse delivery module 908
  • a pulse delivery module can deliver the output signal to the subset of electrodes during a time window associated with at least one a pacing signal or the electrocardiograph signal.
  • the ablation controller and signal generator can be mounted on a rolling trolley, and the user can control the device using a touchscreen interface that is in the sterile field.
  • the touchscreen can be for example an LCD touchscreen in a plastic housing mountable to a standard medical rail or post and can be used to select the electrodes for ablation and to ready the device to fire.
  • the interface can for example be covered with a clear sterile plastic drape.
  • the operator can select the number of electrodes involved in an automated sequence.
  • the touch screen graphically shows the catheters that are attached to the controller. In one embodiment the operator can select electrodes from the touchscreen with appropriate graphical buttons.
  • the operator can also select the pacing stimulus protocol (either internally generated or externally triggered) from the interface.
  • the operator can initiate or verify pacing. Once the operator verifies that the heart is being paced, the ablation sequence can be initiated by holding down a hand-held trigger button that is in the sterile field.
  • the hand-held trigger button can be illuminated red to indicate that the device is “armed” and ready to ablate.
  • the trigger button can be compatible for use in a sterile field and when attached to the controller can be illuminated a different color, for example white.
  • the trigger button flashes in sequence with the pulse delivery in a specific color such as red.
  • the waveform of each delivered pulse is displayed on the touchscreen interface.
  • a graphic representation of the pre and post impedance between electrodes involved in the sequence can also be shown on the interface, and this data can be exported for file storage.
  • an impedance map can be generated based on voltage and current recordings across anode-cathode pairs or sets of electrodes (anodes and cathodes respectively being on distinct catheters), and an appropriate set of electrodes that are best suited for ablation delivery in a given region can be selected based on the impedance map or measurements, either manually by a user or automatically by the system.
  • Such an impedance map can be produced, for example, by the feedback module 905 , or any other suitable portion of the electrode controller 900 .
  • an electrode controller can automatically determine a subset of electrodes to which voltage pulses should be applied.
  • the waveforms for the various electrodes can be displayed and recorded on the case monitor and simultaneously outputted to a standard connection for any electrophysiology (EP) data acquisition system.
  • EP electrophysiology
  • the waveforms acquired internally can be used to autonomously calculate impedances between each electrode pair.
  • the waveform amplitude, period, duty cycle, and delay can all be modified, for example via a suitable Ethernet connection.
  • Pacing for the heart is controlled by the device and outputted to the pacing leads and a protected pacing circuit output for monitoring by a lab.
  • FIG. 7 shows a schematic rendering of a portion of the user interface of the electroporation system.
  • the graphic shown in the FIG. represents a specific choice of electrode subsets for anode and cathode selection.
  • the two PV isolation ablation catheters in the FIG. are represented by strings of numbered electrodes as indicated respectively by 591 and 592 , wrapped around the area 590 of the pulmonary veins represented by the gray region in this schematic diagram for ease of user visualization.
  • the catheters 591 and 592 have proximal leads 651 and 652 respectively that connect to a controller or interface unit as described earlier.
  • the arrows 595 and 596 represent approximate current density vectors, with one end at the cathodes and the other end at the anodes; in this figure, the three electrodes marked 601 and 602 are cathodes, and the single electrode marked 604 is the anode. It is apparent from FIG. 7 that the user can select various subsets of electrodes (respectively on distinct catheters) as cathode or anode, depending on the region to be ablated along the length of the contour around the pulmonary veins represented by the two catheters.
  • the user can make one selection of cathode and anode subsets, and the system can take this selection as input to generate an ablation sequence that moves around the ring or contour defined by the shapes of the two PV isolation catheters, for example moving clockwise at each step with a one-electrode displacement.
  • the pair of cathode and anode electrode subsets can be sequentially updated for ablation purposes, so that if there are N/2 electrodes on each catheter, after N updates the entire contour has been updated such that the current arrows shown as 595 and 596 have swept once around the contour completely.
  • the portion of one of the PV isolation catheters with electrodes may be longer than needed to wrap around a given patient's pulmonary veins; in this event, a smaller number of electrodes is sufficient to wrap around the contour of the pulmonary veins. These define the number of “active” electrodes to be used in the ablation process.
  • the system (any of the generators and controllers described herein) can deliver rectangular-wave pulses with a peak maximum voltage of about 5 kV into a load with an impedance in the range of 30 Ohm to 3000 Ohm for a maximum duration of 200 ⁇ s, with a 100 ⁇ s maximum duration being still more preferred.
  • Pulses can be delivered in a multiplexed and synchronized manner to a multi-electrode catheter inside the body with a duty cycle of up to 50% (for short bursts).
  • the pulses can generally be delivered in bursts, such as for example a sequence of between 2 and 10 pulses interrupted by pauses of between 1 ms and 1000 ms.
  • the multiplexer controller is capable of running an automated sequence to deliver the impulses/impulse trains (from the DC voltage signal/impulse generator) to the tissue target within the body.
  • the controller system is capable of switching between subsets/nodes of electrodes located on the single-use catheters. Further, the controller can measure voltage and current and tabulate impedances in each electrode configuration (for display, planning, and internal diagnostic analysis). It can also generate two channels of cardiac pacing stimulus output, and is capable of synchronizing impulse delivery with the internally generated cardiac pacing and/or an external trigger signal. In one embodiment, it can provide sensing output/connection for access to bio potentials emanating from each electrode connected to the system (with connectivity characteristics being compatible with standard electrophysiological laboratory data acquisition equipment).
  • the controller e.g., the electrode controller 900
  • the controller can automatically “recognize” each of the two single-use disposable catheters when it is connected to the controller output (prompting internal diagnostics and user interface configuration options).
  • the controller can have at least two unique output connector ports (e.g., the first output port 940 and the second output port 942 ) to accommodate up to at least two catheters at once.
  • the controller device can function as long as at least two recognized catheters are attached to it.
  • the controller can have several sequence configurations that provide the operator with at least some variety of programming options.
  • the controller can switch electrode configurations of a bipolar set of electrodes (cathodes and anodes respectively on distinct catheters) sequentially in a clockwise manner (for example, starting at a given step, in the next step of the algorithm, the next cathode electrode on one catheter and the next anode electrode on the other catheter are automatically selected, timed to the synchronizing trigger), with the two catheters and their electrodes arranged in a quasi-circumference around the target.
  • pulse delivery occurs so that the approximate vector of current density changes as the automated sequencing of the controller switches “on” and “off” between different electrodes surrounding the tissue target sequence.
  • the current density vectors generally cross the target tissue but in some configurations the current density could be approximately tangential to the target.
  • the impulses are delivered to user-selected electrode subsets of catheters that are connected to the device (the vector of current density does not change with each synchronized delivery).
  • the user can also configure the controller to deliver up to 2 channels of pacing stimulus to electrodes connected to the device output.
  • the user can control the application of DC voltage with a single handheld switch.
  • a sterile catheter or catheters can be connected to the voltage output of the generator via a connector cable that can be delivered to the sterile field.
  • the user activates the device with a touch screen interface (that can be protected with a single-use sterile transparent disposable cover commonly available in the catheter lab setting).
  • the generator can remain in a standby mode until the user is ready to apply pulses at which point the user/assistant can put the generator into a ready mode via the touchscreen interface. Subsequently the user can select the sequence, the active electrodes, and the cardiac pacing parameters.
  • the user can initiate electrically pacing the heart (using a pacing stimulus generated by the ablation controller or an external source synchronized to the ablation system).
  • the operator verifies that the heart is being paced and uses the hand-held trigger button to apply the synchronized bursts of high voltage pulses.
  • the system can continue delivering the burst pulse train with each cardiac cycle as long as the operator is holding down a suitable “fire” button or switch.
  • the generator output is synchronized with the heart rhythm so that short bursts are delivered at a pre-specified interval from the paced stimulus.
  • the train of pulses is complete, the pacing continues until the operator discontinues pacing.
  • FIG. 8 shows a portion of a user interface of the electroporation system for selection (with graphical button 701 ) of anode and cathode electrodes, with two catheters connected to the system.
  • One of the catheters is a PV isolation catheter 591 while the other is a PV isolation catheter 592 , with their leads schematically indicated by 651 and 652 respectively.
  • the buttons 703 and 704 can enable the selection of marked electrode subsets on the catheters as respectively anode or cathode with a “Continue” button 706 .
  • the appropriate electrodes are colored differently to indicate anode or cathode electrodes as shown marked respectively as 719 and 721 on catheters 592 and 591 respectively in FIG. 9 .
  • the controller and generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes.
  • FIG. 10 shows a rectangular wave pulse train where the pulses 101 have a uniform height or maximum voltage.
  • FIG. 11 shows an example of a balanced biphasic rectangular pulse train, where each positive voltage pulse such as 103 is immediately followed by a negative voltage pulse such as 104 of equal amplitude and opposite sign. While in this example the biphasic pulses are balanced with equal amplitudes of the positive and negative voltages, in other embodiments an unbalanced biphasic waveform could also be used as may be convenient for a given application.
  • FIG. 12 shows a progressive balanced rectangular pulse train, where each distinct biphasic pulse has balanced or equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than its immediate predecessor 106 .
  • FIG. 12 shows a progressive balanced rectangular pulse train, where each distinct biphasic pulse has balanced or equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than its immediate predecessor 106 .
  • Other variations such as a progressive unbalanced rectangular pulse train, or indeed a wide variety of other variations of pulse amplitude with respect to time can be conceived and implemented by those skilled in the art based on the teachings herein.
  • the time duration of each irreversible electroporation rectangular voltage pulse could lie in the range from 1 nanosecond to 10 milliseconds, with the range 10 microseconds to 1 millisecond being more preferable and the range 50 microseconds to 300 microseconds being still more preferable.
  • the time interval between successive pulses of a pulse train could be in the range of 10 microseconds to 1 millisecond, with the range 50 microseconds to 300 microseconds being more preferable.
  • the number of pulses applied in a single pulse train (with delays between individual pulses lying in the ranges just mentioned) can range from 1 to 100, with the range 1 to 10 being more preferable.
  • a pulse train can be driven by a user-controlled switch or button, in one embodiment preferably mounted on a hand-held joystick-like device.
  • a pulse train can be generated for every push of such a control button, while in an alternate mode of operation pulse trains can be generated repeatedly during the refractory periods of a set of successive cardiac cycles, for as long as the user-controlled switch or button is engaged by the user.
  • a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs. Each anode selected in the set of anode/cathode pairs is only in a first set of electrodes of a first multi-electrode catheter. Each cathode selected in the plurality of anode/cathode pairs is only in a second set of electrodes of a second multi-electrode catheter.
  • the first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart, as described herein.
  • the identifying can be based on a predetermined schedule of electrodes. In yet other embodiments, the identifying can be performed automatically based on an impedance measurement or map as described herein.
  • the method further includes conveying a pacing signal to a pacing lead configured to be operatively coupled to the heart, and receiving, at a feedback module of the electrode controller, an electrocardiograph signal associated with a function of the heart.
  • the method further includes delivering, via a pulse delivery module of the electrode controller, a first output signal having a first polarity to each anode selected.
  • the method further includes delivering, via the pulse delivery module, a second output signal having a second polarity to each cathode selected. The first output signal and the second output signal being delivered according to a sequential pattern.
  • Some embodiments described herein relate to a computer storage product with a non-transitory computer-readable medium (also can be referred to as a non-transitory processor-readable medium) having instructions or computer code thereon for performing various computer-implemented operations.
  • the computer-readable medium or processor-readable medium
  • the media and computer code may be those designed and constructed for the specific purpose or purposes.
  • non-transitory computer-readable media include, but are not limited to: magnetic storage media such as hard disks, floppy disks, and magnetic tape; optical storage media such as Compact Disc/Digital Video Discs (CD/DVDs), Compact Disc-Read Only Memories (CD-ROMs), and holographic devices; magneto-optical storage media such as optical disks; carrier wave signal processing modules; and hardware devices that are specially configured to store and execute program code, such as Application-Specific Integrated Circuits (ASICs), Programmable Logic Devices (PLDs), Read-Only Memory (ROM) and Random-Access Memory (RAM) devices.
  • ASICs Application-Specific Integrated Circuits
  • PLDs Programmable Logic Devices
  • ROM Read-Only Memory
  • RAM Random-Access Memory
  • Examples of computer code include, but are not limited to, micro-code or micro-instructions, machine instructions, such as produced by a compiler, code used to produce a web service, and files containing higher-level instructions that are executed by a computer using an interpreter.
  • embodiments may be implemented using imperative programming languages (e.g., C, Fortran, etc.), functional programming languages (Haskell, Erlang, etc.), logical programming languages (e.g., Prolog), object-oriented programming languages (e.g., Java, C++, etc.) or other suitable programming languages and/or development tools.
  • Additional examples of computer code include, but are not limited to, control signals, encrypted code, and compressed code.
  • controller 900 is shown as optionally including the pacing module 902 , in other embodiments, the controller 900 can interface with a separate pacing module.
  • the controller 900 is shown as optionally including the feedback module 905 , in other embodiments, the controller 900 can interface with a separate feedback module.
  • methods and/or events described above indicate certain events and/or procedures occurring in certain order, the ordering of certain events and/or procedures may be modified.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Otolaryngology (AREA)
  • Plasma & Fusion (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Electrotherapy Devices (AREA)
  • Surgical Instruments (AREA)

Abstract

Catheter systems, tools and methods are disclosed for the selective and rapid application of DC voltage to drive irreversible electroporation, with the system controller configurable to apply voltages to an independently selected subsets of electrodes, such that voltages of one polarity are applied to a multiplicity of electrodes on a first medical device and voltages of the opposite polarity to a multiplicity of electrodes on a second medical device. The first and second medical devices can be epicardial catheters positioned such that their opposing distal tips are approximately aligned and whose segments with electrodes collectively wrap around the pulmonary veins.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of PCT Application No. PCT/US2015/031086 titled “METHODS AND APPARATUS FOR MULTI-CATHETER TISSUE ABLATION”, filed May 15, 2015, which claims priority to U.S. Provisional Application Ser. No. 61/996,855, entitled “Method and Apparatus for Rapid Multi-Catheter Tissue Ablation,” filed May 16, 2014, the entire disclosures of which are incorporated herein by reference.
  • BACKGROUND
  • The embodiments described herein relate generally to medical devices for therapeutic electrical energy delivery, and more particularly to systems and methods for delivering electrical energy in the context of ablating tissue rapidly and selectively by the application of suitably timed pulsed voltages that generate irreversible electroporation of cell membranes.
  • The past two decades have seen advances in the technique of electroporation as it has progressed from the laboratory to clinical applications. Known methods include applying brief, high voltage DC pulses to tissue, thereby generating locally high electric fields, typically in the range of hundreds of Volts/centimeter. The electric fields disrupt cell membranes by generating pores in the cell membrane, which subsequently destroys the cell membrane and the cell. While the precise mechanism of this electrically-driven pore generation (or electroporation) awaits a detailed understanding, it is thought that the application of relatively large electric fields generates instabilities in the phospholipid bilayers in cell membranes, as well as mitochondria, causing the occurrence of a distribution of local gaps or pores in the membrane. If the applied electric field at the membrane exceeds a threshold value, typically dependent on cell size, the electroporation is irreversible and the pores remain open, permitting exchange of material across the membrane and leading to apoptosis or cell death. Subsequently, the surrounding tissue heals in a natural process.
  • While pulsed DC voltages are known to drive electroporation under the right circumstances, the examples of electroporation applications in medicine and delivery methods described in the prior art do not discuss specificity of how electrodes are selected to accomplish the desired ablation. For example, some known catheters and systems include a single multi-electrode catheter in which certain electrodes receive a voltage signal having a first polarity and other electrodes receive a voltage signal having the opposite polarity. Accordingly, to minimize the risk of dielectric breakdown within the catheter, such known catheters typically include substantial insulation (e.g., around the leads), thus increasing the size and limiting the flexibility of the catheter. Some known catheters configured to produce voltage pulses of up to 5 kV include catheter leads having an insulation of as much as 0.2 mm and an overall size of about 14 French (4.67 mm).
  • There is a need for selective energy delivery for electroporation and its modulation in various tissue types, as well as pulses that permit rapid action and completion of therapy delivery. This need includes methods and apparatus for placement and therapy delivery from the same device or a set of devices, especially in the context of ablation therapy for cardiac arrhythmias with epicardial catheter devices. There is a need for thin, flexible, atraumatic devices that can, at the same time, effectively deliver high DC voltage electroporation ablation therapy selectively to tissue in regions of interest. Such more selective and effective electroporation delivery methods can broaden the areas of clinical application of electroporation including therapeutic treatment of a variety of cardiac arrhythmias.
  • SUMMARY
  • Catheter systems, tools and methods are disclosed for the selective and rapid application of DC voltage to drive electroporation. In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator. The electrode controller includes a first output port and a second output port. The first output port is configured to be operatively coupled to a first medical device including a first set of electrodes, and the second output port is configured to be operatively coupled to a second medical device including a second set of electrodes. The electrode controller includes a selection module and a pulse delivery module. The selection module is configured to select at least a first electrode from the first set of electrodes and identify at least the first electrode as an anode. The selection module is configured to select at least a second electrode from the second set of electrodes and identify at least the second electrode as a cathode. The pulse delivery module is configured to deliver a first output signal having a first polarity and being associated with the pulsed voltage waveform to the first output port for application to the first electrode. The pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and being associated with the pulsed voltage waveform to the second output port for application to the second electrode.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view showing two catheters according to an embodiment, each with multiple electrodes disposed along its shaft and wrapped around a portion of the pulmonary veins and being within the epicardial space of the heart in a subject body such that they form an approximately closed contour around the pulmonary veins.
  • FIG. 2 is a schematic illustration of a catheter according to an embodiment, with a multiplicity of electrodes disposed along its shaft, with an electrical lead attached to the inner side of each electrode, and with a magnet located near the distal end of the catheter.
  • FIG. 3 illustrates two flexible catheter devices with multiple electrodes disposed along their shafts and positioned to wrap around respective approximate halves of a single closed contour around the pulmonary veins in the epicardial space of the heart, with their distal ends positioned in close proximity.
  • FIG. 4 is an illustration of two flexible catheter devices with multiple electrodes disposed along their shafts and positioned to wrap around respective approximate halves of a single closed contour around the pulmonary veins in the epicardial space of the heart, with active electrodes identified according to an embodiment.
  • FIG. 5A is a schematic illustration of an irreversible electroporation system according to an embodiment that includes a voltage/signal generator, a controller capable of being configured to apply voltages to selected subsets of electrodes with independent subset selections for anode electrodes on one medical device and cathode electrodes on a second medical device.
  • FIG. 5B is a schematic illustration of an irreversible electroporation system according to an embodiment that includes a voltage/signal generator, a controller capable of being configured to apply voltages to selected subsets of electrodes with independent subset selections for anode electrodes on one medical device and cathode electrodes on a second medical device.
  • FIG. 6 is an illustration of an ECG waveform showing the refractory periods during atrial and ventricular pacing, and the time windows for irreversible electroporation ablation.
  • FIG. 7 is a schematic illustration of a method of selecting subsets of electrodes on two catheters as anodes or cathodes, according to an embodiment, whereby the ablation vector or predominant current density direction vector is selected for ablation.
  • FIG. 8 is a schematic illustration of a user interface of the present invention, showing electrodes on two catheters, and buttons for selection or marking of anode electrode subsets and cathode electrode subsets.
  • FIG. 9 is a schematic illustration of a user interface according to an embodiment, for selection of anode and cathode electrode subsets, showing a single selected anode electrode on one catheter and two selected cathode electrodes on a second catheter.
  • FIG. 10 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a balanced square wave.
  • FIG. 11 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a balanced biphasic square wave.
  • FIG. 12 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a progressive balanced biphasic square wave.
  • DETAILED DESCRIPTION
  • Systems and methods are disclosed for the selective and rapid application of DC voltage to drive electroporation. In some embodiments, an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with anode and cathode subsets being selected independently on distinct medical devices. The controller is additionally capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence.
  • In some embodiments, an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with independent subset selections for anode and cathode electrode selections on distinct catheter devices respectively. Further, the controller is capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence. The generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes.
  • In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator. The electrode controller includes a first output port and a second output port. The first output port is configured to be operatively coupled to a first medical device including a first set of electrodes, and the second output port is configured to be operatively coupled to a second medical device including a second set of electrodes. The electrode controller includes a selection module and a pulse delivery module. The selection module is configured to select at least a first electrode from the first set of electrodes and identify at least the first electrode as an anode. The selection module is configured to select at least a second electrode from the second set of electrodes and identify at least the second electrode as a cathode. The pulse delivery module is configured to deliver a first output signal having a first polarity and being associated with the pulsed voltage waveform to the first output port for application to the first electrode. The pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and being associated with the pulsed voltage waveform to the second output port for application to the second electrode.
  • In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator. The electrode controller includes a first output port and a second output port, the first output port configured to be operatively coupled to a first medical device including a first set of electrodes, the second output port configured to be operatively coupled to a second medical device including a second set of electrodes. The electrode controller includes a selection module and a pulse delivery module. The selection module is configured to select a set of anode/cathode pairs, each anode selected being only in the first plurality of electrodes, each cathode selected being only in the second plurality of electrodes. The pulse delivery module is configured to deliver a first output signal having a first polarity and associated with the pulsed voltage waveform to the first output port for application to each anode selected. The pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and associated with the pulsed voltage waveform to the second output port for application to each cathode selected. The pulse delivery module is configured to deliver the first output signal and the second output signal to the plurality of anode/cathode pairs according to a sequential pattern.
  • Methods of control and DC voltage application from a generator capable of selective excitation of sets of electrodes are also disclosed herein. In some embodiments, a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs, each anode selected being only in a first set of electrodes of a first multi-electrode catheter, each cathode selected being only in a second set of electrodes of a second multi-electrode catheter. The first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart. A pacing signal is conveyed to a pacing lead configured to be operatively coupled to the heart. The method includes receiving, at a feedback module, an electrocardiograph signal associated with a function of the heart. The method includes delivering, via a pulse delivery module of the electrode controller, a first output signal having a first polarity to each anode selected, and delivering, via the pulse delivery module, a second output signal having a second polarity opposite the first polarity to each cathode selected. The first output signal and the second output signal are delivered according to a sequential pattern.
  • In some embodiments, a non-transitory processor readable medium storing code representing instructions to be executed by a processor includes code to cause the processor to identify a set of anode/cathode pairs. Each anode in the plurality of anode/cathode pairs being only in a first set of electrodes of a first multi-electrode catheter. Each cathode in the set of anode/cathode pairs being only in a second set of electrodes of a second multi-electrode catheter. The first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart. The code further includes code to convey a pacing signal to a pacing lead configured to be operatively coupled to the heart, and receive an electrocardiograph signal associated with a function of the heart. The code further includes code to deliver, according to a sequential pattern, a first output signal having a first polarity to each anode selected and a second output signal having a second polarity opposite the first polarity to each cathode selected.
  • In some embodiments system includes a first flexible catheter including a first set of electrodes and a second flexible catheter including a second set of electrodes. A distal end portion of the first flexible catheter is configured to be coupled to a distal end portion of the second catheter to form a continuous length including the first set of electrodes and the second set of electrodes. The first flexible catheter and the second flexible catheter are configured to deliver a bipolar voltage signal to a target tissue such that a first portion of the bipolar voltage signal having a first polarity is delivered only to the first set of electrodes and a second portion of the bipolar voltage signal having second polarity opposite the first polarity is delivered only to the second set of electrodes.
  • As used in this specification, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, the term “a member” is intended to mean a single member or a combination of members, “a material” is intended to mean one or more materials, “a processor” is intended to mean a single processor or multiple processors; and “memory” is intended to mean one or more memories, or a combination thereof.
  • As used herein, the terms “about” and “approximately” generally mean plus or minus 10% of the value stated. For example, about 0.5 would include 0.45 and 0.55, about 10 would include 9 to 11, about 1000 would include 900 to 1100.
  • As shown in FIG. 1, in some embodiments a Pulmonary Vein isolation (PV isolation) system includes two ablation catheter devices, one (labeled 5) with distal end 15 and proximal portion 8, the other (labeled 6) with distal end 16 and proximal portion 9, each with a multiplicity of electrodes (indicated by dark bands such as those marked as 19) disposed along its length, and where each catheter is wrapped in the epicardial space around a portion of the pulmonary veins 10, 11, 12 and 13 of a heart 7 in a subject or patient anatomy, with the proximal portions 8 and 9 of the respective catheters 5 and 6 extending out and away to eventually emerge from the patient's chest. In some embodiments, the distal ends of the two catheters 5 and 6 have magnets 15 and 16 respectively that can aid in alignment of the two catheters. The ablation catheters 5 and 6, and any of the catheters described herein can be similar to the ablation catheters described in PCT Publication No. WO2014/025394, entitled “Catheters, Catheter Systems, and Methods for Puncturing Through a Tissue Structure,” filed on Mar. 14, 2013 (“the '394 PCT Application), which is incorporated herein by reference in its entirety. The ablation catheters 5 and 6 can be disposed about the pulmonary veins 10, 11, 12 and 13 using any suitable procedure and apparatus. For example, in some embodiments, the ablation catheters can be disposed about the pulmonary veins 10, 11, 12 and 13 and/or the heart 7 using a puncturing apparatus disposed via a subxiphoid pericardial access location and a using guidewire-based delivery method as described in the '394 PCT Application. Similar methods can be used to deliver and position the two catheters 5 and 6. After the ends 8 and 9 of the two respective catheters 5 and 6 extend and emerge out of the patient chest they can be cinched together to effectively hold the catheters in place or in stable positions relative to each other.
  • A DC voltage for electroporation can be applied to subsets of electrodes identified as anodes and cathodes respectively on the two catheters on approximately opposite sides of the closed contour defined by the shapes of the catheters 5 and 6 around the pulmonary veins. The DC voltage is applied in brief pulses sufficient to cause irreversible electroporation and can be in the range of 0.5 kV to 10 kV and more preferably in the range 1 kV to 2.5 kV, so that a threshold electric field value of around 200 Volts/cm is effectively achieved in the cardiac tissue to be ablated. In some embodiments, the marked or active electrodes on the two catheters can be automatically identified, or manually identified by suitable marking, on an X-ray or fluoroscopic image obtained at an appropriate angulation that permits identification of the geometric distance between anode and cathode electrodes, or their respective centroids. In one embodiment, the DC voltage generator setting for irreversible electroporation is then automatically identified by the electroporation system based on this distance measure. In an alternate embodiment, the DC voltage value is selected directly by a user from a suitable dial, slider, touch screen, or any other user interface. The DC voltage pulse results in a current flowing between the anode and cathode electrodes on opposite sides of the contour defined by the conjoint shapes of the two catheters, with said current flowing through the cardiac wall tissue and through the intervening blood in the cardiac chamber, with the current entering the cardiac tissue from the anode electrodes and returning back through the cathode electrodes. The forward and return current paths (leads) are respectively inside distinct catheters, since all active electrodes on a given catheter are of like polarity. Areas of cardiac wall tissue where the electric field is sufficiently large for irreversible electroporation are ablated during the DC voltage pulse application.
  • FIG. 2 is a schematic illustration of a multi-electrode, magnet-tipped catheter according to an embodiment. The catheter shaft 801 has a multiplicity of electrodes disposed along an extensive length of catheter at least 5 cm in extent. In some embodiments the metallic electrodes could be poly-metallic in construction, for example, including regions of Titanium and regions of Platinum. Although FIG. 2 shows only four electrodes 803, 804, 805 and 806 for clarity, in other embodiments, the number of electrodes can be in the range between 5 and 30, and more preferably in the range between 8 and 18. Each electrode attaches to a corresponding lead, thus as shown in FIG. 2, electrodes 803, 804, 805 and 806 attach to leads 813, 814, 815 and 816, respectively.
  • The catheter shaft is made of a flexible polymeric material such as for example Teflon, Nylon or Pebax. Moreover, the leads 813, 814, 815 and 816 include an insulative covering to ensure that each lead/electrode is electrically isolated from the other leads and electrodes coupled to the catheter shaft 801. When the catheter device is used with the systems and methods described herein, all of the electrodes 803, 804, 805 and 806 of the catheter 801 have the same polarity. Thus, the need for high dielectric strength material separating the leads is not a significant constraint. Accordingly, the insulative material covering each lead can be minimized, and the catheter can be relatively small in diameter. In this manner, the catheter device can have a high degree of flexibility to facilitate the method of surrounding the pulmonary veins as described herein. In some embodiments, for example, the catheter device can have a size in the range of approximately 9 French (3 mm), 8 French (2.67 mm) or even 6 French (2 mm). In some embodiments, the electrode leads of the catheter device can have an insulation thickness of less than about 0.05 mm, less than about 0.01 m, or less than about 0.005 mm. In other embodiments, the electrode leads of the catheter can have an insulation thickness of between about 0.03 mm and about 0.06 mm.
  • Moreover, by maintaining the voltage for each of the electrodes 803, 804, 805 and 806 of the catheter 801 at the same polarity, higher voltage levels can be applied to the electrodes of the catheter with minimal risk of dielectric breakdown. In this manner, the catheter device 801 (and the systems and methods described herein) can enhance the efficacy of irreversible electroporation ablation. For example, in some embodiments, the voltage applied to the electrodes 803, 804, 805 and 806 can be in the range of 0.5 kV to 2.5 kV; 2.5 kV to 5 kV, and up to 10 kV and more preferably in the range 1 kV to 2.5 kV.
  • As shown in FIG. 2, the distal end of the catheter 801 has a ring-shaped magnet 809, with the magnet having a magnetization direction that is substantially aligned with the longitudinal axis of the catheter. The magnet 809 is configured to have a polarity to cooperate with a corresponding magnet from a second catheter to be used in conjunction with the catheter 801. For example, the magnets 15 and 16 shown respectively at the distal ends of the two catheters 5 and 6 in FIG. 1 have opposite polarities on their distal faces, so that they attract each other. This attraction can aid in approximate alignment and/or coupling of the catheters. With two distinct catheters, anode and cathode electrodes for voltage application can be selected on distinct devices in accordance with the methods described herein.
  • Additionally, by using two catheters to deliver a bipolar pulse, but maintaining the voltage for each of the electrodes within each catheter at the same polarity, according to the methods described herein, each of the catheters includes fewer electrodes and few leads than if a single catheter were used to surround the heart. The reduction of the number of leads and electrodes also allows for an overall reduction in the size of the catheter, improvement in the flexibility thereof, and the like.
  • In some embodiments, for example, a system includes a first catheter including a first set of electrodes and a second flexible catheter including a second set of electrodes. Each of the catheters can be, for example, the catheter 801. A distal end portion of the first flexible catheter is configured to be coupled to a distal end portion of the second catheter to form a continuous length including the first set of electrodes and the second set of electrodes. The connection can be via a magnetic coupling device, as shown herein. The first flexible catheter and the second flexible catheter are configured to deliver a bipolar voltage signal to a target tissue such that a first portion of the bipolar voltage signal having a first polarity is delivered only to the first set of electrodes and a second portion of the bipolar voltage signal having second polarity opposite the first polarity is delivered only to the second set of electrodes.
  • FIG. 3 shows another example of the placement of a first catheter 538 and a second catheter 539, according to an embodiment. The first catheter 538 and the second catheter 539 can each be constructed of a small diameter tube covered by multiple metal electrodes. The distal ends of the catheters (544 and 554 respectively) contain magnets that attract and allow for alignment of the devices when their distal ends are in close proximity as indicated by region 545. Electrodes 543 disposed along the first catheter 538 are of a single polarity (for instance, an activated subset of the electrodes would all be anodes), while electrodes 553 disposed along the second catheter 539 are all of the opposite polarity (in the same example, an activated subset could all be cathodes). Wires are connected to each electrode in the anode and cathode catheters, indicated by collective anode leads 542 and collective cathode leads 552 respectively. Thus, wires of opposite polarity are not in the same catheter, thereby reducing the possibility of dielectric breakdown at high voltage, as discussed above. Furthermore, when it is desired to reduce the catheter diameter and the number of leads within a given catheter, it may also be advantageous to use two distinct catheters, with the pair of catheters surround and/or substantially enclosing the pulmonary veins and with their distal ends closely abutting. Reduced diameter catheters can be significantly more flexible and a smaller number of leads in a given catheter (resulting in a smaller catheter diameter) can be advantageous in this regard. While in this example the two catheters are navigated and coupled magnetically, those skilled in the art could implement other means of alignment and positioning of the catheters without departing from the scope of the teachings herein.
  • The illustration in FIG. 4 shows the first catheter 538 and the second catheter 539 having proximal leads 542 and 552, respectively, and having distal ends 544 and 554, respectively. In accordance with the systems and methods described herein, the a single active anode electrode 604 is selected on the second catheter 539, and two active cathode electrodes 601 and 602 are selected on the first catheter 538. A DC voltage for irreversible electroporation ablation can then be applied across the selected anode-cathode electrodes.
  • A schematic diagram of an electroporation system according to an embodiment is shown in FIG. 5A. The system includes a DC voltage/signal generator 23 that is driven by a controller unit 21. The controller unit 21 interfaces with a computer device 24 by means of a two-way communication link 29. The controller interface can act as a multiplexer unit and perform channel selection and routing functions for applying DC voltages to appropriate electrodes that have been selected by a user or by the computer 24. The controller can apply the voltages via a multiplicity of leads to a first catheter device 22, as well as a second catheter device 122. Active electrodes can be selected on a first catheter device 22 with one polarity, and likewise active electrodes can be selected on a second catheter device 122 with the opposite polarity.
  • In some embodiments, one or more leads from the controller 21 could also carry pacing signals to drive pacing of the heart through a separate pacing device (not shown). The catheter devices can also send back information such as ECG recordings or data from other sensors back to the controller 21, possibly on separate leads. While the DC voltage generator 23 sends a DC voltage to the controller 21 through leads 27, the voltage generator is driven by control and timing inputs 28 from the controller unit 21.
  • As shown in FIG. 6, given atrial or ventricular pacing inputs to the heart, the resulting ECG waveform 32 has appropriate respective refractory time intervals 33 and 34 respectively, during which there are suitable time windows for application of irreversible electroporation as indicated by 35 and 36. The application of cardiac pacing results in a periodic, well-controlled sequence of electroporation time windows. Typically, this time window is of the order of hundreds of microseconds to about a millisecond or more. During this window, multiple DC voltage pulses can be applied to ensure that sufficient tissue ablation has occurred. The user can repeat the delivery of irreversible electroporation over several successive cardiac cycles for further confidence. Thus, in some embodiments, a feedback module (e.g., feedback module 905) can receive the electrocardiograph signal, and a pulse delivery module (e.g., pulse delivery module 908) can deliver the output signal to the subset of electrodes during a time window associated with at least one a pacing signal or the electrocardiograph signal.
  • In one embodiment, the ablation controller and signal generator can be mounted on a rolling trolley, and the user can control the device using a touchscreen interface that is in the sterile field. The touchscreen can be for example an LCD touchscreen in a plastic housing mountable to a standard medical rail or post and can be used to select the electrodes for ablation and to ready the device to fire. The interface can for example be covered with a clear sterile plastic drape. The operator can select the number of electrodes involved in an automated sequence. The touch screen graphically shows the catheters that are attached to the controller. In one embodiment the operator can select electrodes from the touchscreen with appropriate graphical buttons. The operator can also select the pacing stimulus protocol (either internally generated or externally triggered) from the interface. Once pacing is enabled, and the ablation sequence is selected, the operator can initiate or verify pacing. Once the operator verifies that the heart is being paced, the ablation sequence can be initiated by holding down a hand-held trigger button that is in the sterile field. The hand-held trigger button can be illuminated red to indicate that the device is “armed” and ready to ablate. The trigger button can be compatible for use in a sterile field and when attached to the controller can be illuminated a different color, for example white. When the device is firing, the trigger button flashes in sequence with the pulse delivery in a specific color such as red. The waveform of each delivered pulse is displayed on the touchscreen interface. A graphic representation of the pre and post impedance between electrodes involved in the sequence can also be shown on the interface, and this data can be exported for file storage.
  • In one embodiment, an impedance map can be generated based on voltage and current recordings across anode-cathode pairs or sets of electrodes (anodes and cathodes respectively being on distinct catheters), and an appropriate set of electrodes that are best suited for ablation delivery in a given region can be selected based on the impedance map or measurements, either manually by a user or automatically by the system. Such an impedance map can be produced, for example, by the feedback module 905, or any other suitable portion of the electrode controller 900. For example, if the impedance across an anode/cathode combination of electrodes is a relatively low value (for example, less than 25 Ohms), at a given voltage the said combination would result in relatively large currents in the tissue and power dissipation in tissue. In such circumstances, this electrode combination would then be ruled out for ablation due to safety considerations (e.g., via the selection module 912), and alternate electrode combinations would be sought by the user. In a preferred embodiment, a pre-determined range of impedance values, for example 30 Ohms to 300 Ohms, could be used as an allowed impedance range within which it is deemed safe to ablate. Thus, in some embodiments, an electrode controller can automatically determine a subset of electrodes to which voltage pulses should be applied.
  • The waveforms for the various electrodes can be displayed and recorded on the case monitor and simultaneously outputted to a standard connection for any electrophysiology (EP) data acquisition system. With the high voltages involved with the device, the outputs to the EP data acquisition system needs to be protected from voltage and/or current surges. The waveforms acquired internally can be used to autonomously calculate impedances between each electrode pair. The waveform amplitude, period, duty cycle, and delay can all be modified, for example via a suitable Ethernet connection. Pacing for the heart is controlled by the device and outputted to the pacing leads and a protected pacing circuit output for monitoring by a lab.
  • While a touchscreen interface is one preferred embodiment, other user interfaces can be used by a user to control the system such as a graphical display on a laptop or monitor display controlled by a standard computer mouse or joystick. FIG. 7 shows a schematic rendering of a portion of the user interface of the electroporation system. The graphic shown in the FIG. represents a specific choice of electrode subsets for anode and cathode selection. The two PV isolation ablation catheters in the FIG. are represented by strings of numbered electrodes as indicated respectively by 591 and 592, wrapped around the area 590 of the pulmonary veins represented by the gray region in this schematic diagram for ease of user visualization. The catheters 591 and 592 have proximal leads 651 and 652 respectively that connect to a controller or interface unit as described earlier. Referring to the figure, the arrows 595 and 596 represent approximate current density vectors, with one end at the cathodes and the other end at the anodes; in this figure, the three electrodes marked 601 and 602 are cathodes, and the single electrode marked 604 is the anode. It is apparent from FIG. 7 that the user can select various subsets of electrodes (respectively on distinct catheters) as cathode or anode, depending on the region to be ablated along the length of the contour around the pulmonary veins represented by the two catheters. In one embodiment, the user can make one selection of cathode and anode subsets, and the system can take this selection as input to generate an ablation sequence that moves around the ring or contour defined by the shapes of the two PV isolation catheters, for example moving clockwise at each step with a one-electrode displacement. In this manner, the pair of cathode and anode electrode subsets can be sequentially updated for ablation purposes, so that if there are N/2 electrodes on each catheter, after N updates the entire contour has been updated such that the current arrows shown as 595 and 596 have swept once around the contour completely.
  • In some cases, the portion of one of the PV isolation catheters with electrodes may be longer than needed to wrap around a given patient's pulmonary veins; in this event, a smaller number of electrodes is sufficient to wrap around the contour of the pulmonary veins. These define the number of “active” electrodes to be used in the ablation process.
  • In a some embodiments, the system (any of the generators and controllers described herein) can deliver rectangular-wave pulses with a peak maximum voltage of about 5 kV into a load with an impedance in the range of 30 Ohm to 3000 Ohm for a maximum duration of 200 μs, with a 100 μs maximum duration being still more preferred. Pulses can be delivered in a multiplexed and synchronized manner to a multi-electrode catheter inside the body with a duty cycle of up to 50% (for short bursts). The pulses can generally be delivered in bursts, such as for example a sequence of between 2 and 10 pulses interrupted by pauses of between 1 ms and 1000 ms. The multiplexer controller is capable of running an automated sequence to deliver the impulses/impulse trains (from the DC voltage signal/impulse generator) to the tissue target within the body. The controller system is capable of switching between subsets/nodes of electrodes located on the single-use catheters. Further, the controller can measure voltage and current and tabulate impedances in each electrode configuration (for display, planning, and internal diagnostic analysis). It can also generate two channels of cardiac pacing stimulus output, and is capable of synchronizing impulse delivery with the internally generated cardiac pacing and/or an external trigger signal. In one embodiment, it can provide sensing output/connection for access to bio potentials emanating from each electrode connected to the system (with connectivity characteristics being compatible with standard electrophysiological laboratory data acquisition equipment).
  • In some embodiments, the controller (e.g., the electrode controller 900) can automatically “recognize” each of the two single-use disposable catheters when it is connected to the controller output (prompting internal diagnostics and user interface configuration options). The controller can have at least two unique output connector ports (e.g., the first output port 940 and the second output port 942) to accommodate up to at least two catheters at once. The controller device can function as long as at least two recognized catheters are attached to it. In some embodiments, the controller can have several sequence configurations that provide the operator with at least some variety of programming options. In one configuration, the controller can switch electrode configurations of a bipolar set of electrodes (cathodes and anodes respectively on distinct catheters) sequentially in a clockwise manner (for example, starting at a given step, in the next step of the algorithm, the next cathode electrode on one catheter and the next anode electrode on the other catheter are automatically selected, timed to the synchronizing trigger), with the two catheters and their electrodes arranged in a quasi-circumference around the target. Thus in the first sequence, pulse delivery occurs so that the approximate vector of current density changes as the automated sequencing of the controller switches “on” and “off” between different electrodes surrounding the tissue target sequence. The current density vectors generally cross the target tissue but in some configurations the current density could be approximately tangential to the target. In a second sequence configuration, the impulses are delivered to user-selected electrode subsets of catheters that are connected to the device (the vector of current density does not change with each synchronized delivery). The user can also configure the controller to deliver up to 2 channels of pacing stimulus to electrodes connected to the device output. The user can control the application of DC voltage with a single handheld switch. A sterile catheter or catheters can be connected to the voltage output of the generator via a connector cable that can be delivered to the sterile field. In one embodiment, the user activates the device with a touch screen interface (that can be protected with a single-use sterile transparent disposable cover commonly available in the catheter lab setting). The generator can remain in a standby mode until the user is ready to apply pulses at which point the user/assistant can put the generator into a ready mode via the touchscreen interface. Subsequently the user can select the sequence, the active electrodes, and the cardiac pacing parameters.
  • Once the catheters have been advanced to or around the cardiac target, the user can initiate electrically pacing the heart (using a pacing stimulus generated by the ablation controller or an external source synchronized to the ablation system). The operator verifies that the heart is being paced and uses the hand-held trigger button to apply the synchronized bursts of high voltage pulses. The system can continue delivering the burst pulse train with each cardiac cycle as long as the operator is holding down a suitable “fire” button or switch. During the application of the pulses, the generator output is synchronized with the heart rhythm so that short bursts are delivered at a pre-specified interval from the paced stimulus. When the train of pulses is complete, the pacing continues until the operator discontinues pacing.
  • FIG. 8 shows a portion of a user interface of the electroporation system for selection (with graphical button 701) of anode and cathode electrodes, with two catheters connected to the system. One of the catheters is a PV isolation catheter 591 while the other is a PV isolation catheter 592, with their leads schematically indicated by 651 and 652 respectively. The buttons 703 and 704 can enable the selection of marked electrode subsets on the catheters as respectively anode or cathode with a “Continue” button 706. Once the selection is made, the appropriate electrodes are colored differently to indicate anode or cathode electrodes as shown marked respectively as 719 and 721 on catheters 592 and 591 respectively in FIG. 9.
  • The controller and generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes. FIG. 10 shows a rectangular wave pulse train where the pulses 101 have a uniform height or maximum voltage. FIG. 11 shows an example of a balanced biphasic rectangular pulse train, where each positive voltage pulse such as 103 is immediately followed by a negative voltage pulse such as 104 of equal amplitude and opposite sign. While in this example the biphasic pulses are balanced with equal amplitudes of the positive and negative voltages, in other embodiments an unbalanced biphasic waveform could also be used as may be convenient for a given application.
  • Yet another example of a waveform or pulse shape that can be generated by the system is illustrated in FIG. 12, which shows a progressive balanced rectangular pulse train, where each distinct biphasic pulse has balanced or equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than its immediate predecessor 106. Other variations such as a progressive unbalanced rectangular pulse train, or indeed a wide variety of other variations of pulse amplitude with respect to time can be conceived and implemented by those skilled in the art based on the teachings herein.
  • The time duration of each irreversible electroporation rectangular voltage pulse could lie in the range from 1 nanosecond to 10 milliseconds, with the range 10 microseconds to 1 millisecond being more preferable and the range 50 microseconds to 300 microseconds being still more preferable. The time interval between successive pulses of a pulse train could be in the range of 10 microseconds to 1 millisecond, with the range 50 microseconds to 300 microseconds being more preferable. The number of pulses applied in a single pulse train (with delays between individual pulses lying in the ranges just mentioned) can range from 1 to 100, with the range 1 to 10 being more preferable. As described in the foregoing, a pulse train can be driven by a user-controlled switch or button, in one embodiment preferably mounted on a hand-held joystick-like device. In one mode of operation a pulse train can be generated for every push of such a control button, while in an alternate mode of operation pulse trains can be generated repeatedly during the refractory periods of a set of successive cardiac cycles, for as long as the user-controlled switch or button is engaged by the user.
  • In some embodiments, a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs. Each anode selected in the set of anode/cathode pairs is only in a first set of electrodes of a first multi-electrode catheter. Each cathode selected in the plurality of anode/cathode pairs is only in a second set of electrodes of a second multi-electrode catheter. The first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart, as described herein. In some embodiments, the identifying can be based on a predetermined schedule of electrodes. In yet other embodiments, the identifying can be performed automatically based on an impedance measurement or map as described herein.
  • The method further includes conveying a pacing signal to a pacing lead configured to be operatively coupled to the heart, and receiving, at a feedback module of the electrode controller, an electrocardiograph signal associated with a function of the heart.
  • The method further includes delivering, via a pulse delivery module of the electrode controller, a first output signal having a first polarity to each anode selected. The method further includes delivering, via the pulse delivery module, a second output signal having a second polarity to each cathode selected. The first output signal and the second output signal being delivered according to a sequential pattern.
  • Some embodiments described herein relate to a computer storage product with a non-transitory computer-readable medium (also can be referred to as a non-transitory processor-readable medium) having instructions or computer code thereon for performing various computer-implemented operations. The computer-readable medium (or processor-readable medium) is non-transitory in the sense that it does not include transitory propagating signals per se (e.g., a propagating electromagnetic wave carrying information on a transmission medium such as space or a cable). The media and computer code (also can be referred to as code) may be those designed and constructed for the specific purpose or purposes. Examples of non-transitory computer-readable media include, but are not limited to: magnetic storage media such as hard disks, floppy disks, and magnetic tape; optical storage media such as Compact Disc/Digital Video Discs (CD/DVDs), Compact Disc-Read Only Memories (CD-ROMs), and holographic devices; magneto-optical storage media such as optical disks; carrier wave signal processing modules; and hardware devices that are specially configured to store and execute program code, such as Application-Specific Integrated Circuits (ASICs), Programmable Logic Devices (PLDs), Read-Only Memory (ROM) and Random-Access Memory (RAM) devices.
  • Examples of computer code include, but are not limited to, micro-code or micro-instructions, machine instructions, such as produced by a compiler, code used to produce a web service, and files containing higher-level instructions that are executed by a computer using an interpreter. For example, embodiments may be implemented using imperative programming languages (e.g., C, Fortran, etc.), functional programming languages (Haskell, Erlang, etc.), logical programming languages (e.g., Prolog), object-oriented programming languages (e.g., Java, C++, etc.) or other suitable programming languages and/or development tools. Additional examples of computer code include, but are not limited to, control signals, encrypted code, and compressed code.
  • While various specific examples and embodiments of systems and tools for selective tissue ablation with irreversible electroporation were described in the foregoing for illustrative and exemplary purposes, it should be clear that a wide variety of variations and alternate embodiments could be conceived or constructed by those skilled in the art based on the teachings herein. While specific methods of control and DC voltage application from a generator capable of selective excitation of sets of electrodes were disclosed, persons skilled in the art would recognize that any of a wide variety of other control or user input methods and methods of electrode subset selection etc. can be implemented without departing from the scope of the present invention. Likewise, while the foregoing described a range of specific tools or devices for more effective and selective DC voltage application for irreversible electroporation through ionic fluid irrigation and ultrasonic agitation, including insulating balloon constructions, focal ablation tools, and a basket catheter with a multiplicity of, other device constructions or variations could be implemented by one skilled in the art by employing the principles and teachings disclosed herein without departing from the scope of the present invention, in the treatment of cardiac arrhythmias, in intravascular applications, or a variety of other medical applications.
  • Furthermore, while the present disclosure describes specific embodiments and tools involving irrigation with saline fluids and the use of temperature to selectively ablate tissue by taking advantage of the temperature-dependence of the threshold of irreversible electroporation, it should be clear to one skilled in the art that a variety of methods and devices for steady fluid delivery, or for tissue heating through the delivery of focused kinetic energy or electromagnetic radiation could be implemented utilizing the methods and principles taught herein without departing from the scope of the present invention.
  • Where schematics and/or embodiments described above indicate certain components arranged in certain orientations or positions, the arrangement of components may be modified. For example, although the controller 900 is shown as optionally including the pacing module 902, in other embodiments, the controller 900 can interface with a separate pacing module. For example, although the controller 900 is shown as optionally including the feedback module 905, in other embodiments, the controller 900 can interface with a separate feedback module. Similarly, where methods and/or events described above indicate certain events and/or procedures occurring in certain order, the ordering of certain events and/or procedures may be modified.
  • Although various embodiments have been described as having particular features and/or combinations of components, other embodiments are possible having a combination of any features and/or components from any of embodiments as discussed above.

Claims (14)

1-16. (canceled)
17. A method, comprising:
identifying, via a selection module of an electrode controller, a plurality of anode/cathode pairs, each anode selected in the plurality of anode/cathode pairs being only in a first plurality of electrodes of a first multi-electrode catheter, each cathode selected in the plurality of anode/cathode pairs being only in a second plurality of electrodes of a second multi-electrode catheter, the first multi-electrode catheter and the second multi-electrode catheter configured to collectively surround a portion of a heart;
conveying a pacing signal to a pacing lead configured to be operatively coupled to the heart;
delivering, via a pulse delivery module of the electrode controller, a first output signal having a first polarity to each anode selected; and
delivering, via the pulse delivery module, a second output signal having a second polarity opposite the first polarity to each cathode selected, the first output signal and the second output signal being delivered according to a sequential pattern.
18. The method of claim 17, wherein the identifying is based on an input received from an input/output module of the electrode controller.
19. The method of claim 17, further comprising:
computing an impedance between at least one anode electrode in the first plurality of electrodes and at least one cathode electrode in the second plurality of electrodes,
the identifying being performed automatically by the selection module based at least in part on the impedance.
20. The method of claim 17, further comprising:
generating the sequential pattern based on at least one of an impedance associated with the plurality of anode/cathode pairs, a distance between the plurality of anode/cathode pairs, and a characteristic associated with the heart.
21. The method of claim 17, wherein the first multi-electrode catheter is electrically isolated from the second multi-electrode catheter.
22. The method of claim 17, wherein the portion of the heart includes one or more of the pulmonary veins.
23. A non-transitory processor readable medium storing code representing instructions to be executed by a processor, the code comprising code to cause the processor to:
identify a plurality of anode/cathode pairs, each anode in the plurality of anode/cathode pairs being only in a first plurality of electrodes of a first multi-electrode catheter, each cathode in the plurality of anode/cathode pairs being only in a second plurality of electrodes of a second multi-electrode catheter, the first multi-electrode catheter and the second multi-electrode catheter configured to collectively surround a portion of a heart;
convey a pacing signal to a pacing lead configured to be operatively coupled to the heart;
and
deliver, according to a sequential pattern, a first output signal having a first polarity to each anode selected and a second output signal having a second polarity opposite the first polarity to each cathode selected.
24-28. (canceled)
29. The method of claim 17, further comprising:
receiving, at a feedback module, an electrocardiograph signal associated with the heart.
30. The non-transitory processor readable medium of claim 23, further comprising:
computing an impedance between at least one electrode in the first plurality of electrodes and at least one electrode in the second plurality of electrodes,
the identifying being performed automatically based on the impedance.
31. The non-transitory processor readable medium of claim 23, further comprising:
generating the sequential pattern based on at least one of an impedance associated with the plurality of anode/cathode pairs, a distance between the plurality of anode/cathode pairs, and a characteristic associated with the heart.
32. The non-transitory processor readable medium of claim 23, further comprising:
receiving an electrocardiograph signal associated with the heart.
33. The non-transitory processor readable medium of claim 23, wherein the portion of the heart includes one or more of the pulmonary veins.
US15/795,075 2014-05-16 2017-10-26 Methods and apparatus for multi-catheter tissue ablation Abandoned US20180042675A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US15/795,075 US20180042675A1 (en) 2014-05-16 2017-10-26 Methods and apparatus for multi-catheter tissue ablation
US17/207,053 US12137968B2 (en) 2014-05-16 2021-03-19 Methods and apparatus for multi-catheter tissue ablation
US18/943,623 US20250064511A1 (en) 2014-05-16 2024-11-11 Methods and apparatus for multi-catheter tissue ablation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461996855P 2014-05-16 2014-05-16
PCT/US2015/031086 WO2015175944A1 (en) 2014-05-16 2015-05-15 Methods and apparatus for multi-catheter tissue ablation
US15/341,523 US20170065340A1 (en) 2014-05-16 2016-11-02 Methods and apparatus for multi-catheter tissue ablation
US15/795,075 US20180042675A1 (en) 2014-05-16 2017-10-26 Methods and apparatus for multi-catheter tissue ablation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/341,523 Continuation US20170065340A1 (en) 2014-05-16 2016-11-02 Methods and apparatus for multi-catheter tissue ablation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/207,053 Continuation US12137968B2 (en) 2014-05-16 2021-03-19 Methods and apparatus for multi-catheter tissue ablation

Publications (1)

Publication Number Publication Date
US20180042675A1 true US20180042675A1 (en) 2018-02-15

Family

ID=53276301

Family Applications (4)

Application Number Title Priority Date Filing Date
US15/341,523 Abandoned US20170065340A1 (en) 2014-05-16 2016-11-02 Methods and apparatus for multi-catheter tissue ablation
US15/795,075 Abandoned US20180042675A1 (en) 2014-05-16 2017-10-26 Methods and apparatus for multi-catheter tissue ablation
US17/207,053 Active 2036-04-04 US12137968B2 (en) 2014-05-16 2021-03-19 Methods and apparatus for multi-catheter tissue ablation
US18/943,623 Pending US20250064511A1 (en) 2014-05-16 2024-11-11 Methods and apparatus for multi-catheter tissue ablation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US15/341,523 Abandoned US20170065340A1 (en) 2014-05-16 2016-11-02 Methods and apparatus for multi-catheter tissue ablation

Family Applications After (2)

Application Number Title Priority Date Filing Date
US17/207,053 Active 2036-04-04 US12137968B2 (en) 2014-05-16 2021-03-19 Methods and apparatus for multi-catheter tissue ablation
US18/943,623 Pending US20250064511A1 (en) 2014-05-16 2024-11-11 Methods and apparatus for multi-catheter tissue ablation

Country Status (3)

Country Link
US (4) US20170065340A1 (en)
EP (1) EP3142584A1 (en)
WO (1) WO2015175944A1 (en)

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9987081B1 (en) 2017-04-27 2018-06-05 Iowa Approach, Inc. Systems, devices, and methods for signal generation
US10130423B1 (en) 2017-07-06 2018-11-20 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10172673B2 (en) 2016-01-05 2019-01-08 Farapulse, Inc. Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10322286B2 (en) 2016-01-05 2019-06-18 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10368936B2 (en) 2014-11-17 2019-08-06 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10433906B2 (en) 2014-06-12 2019-10-08 Farapulse, Inc. Method and apparatus for rapid and selective transurethral tissue ablation
US10470826B2 (en) 2012-05-21 2019-11-12 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10499986B2 (en) 2007-11-16 2019-12-10 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US10507302B2 (en) 2016-06-16 2019-12-17 Farapulse, Inc. Systems, apparatuses, and methods for guide wire delivery
US10512505B2 (en) 2018-05-07 2019-12-24 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10517672B2 (en) 2014-01-06 2019-12-31 Farapulse, Inc. Apparatus and methods for renal denervation ablation
US10568576B2 (en) 2012-05-21 2020-02-25 Kardium Inc. Systems and methods for activating transducers
US10617867B2 (en) 2017-04-28 2020-04-14 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
US10624693B2 (en) 2014-06-12 2020-04-21 Farapulse, Inc. Method and apparatus for rapid and selective tissue ablation with cooling
US10625080B1 (en) 2019-09-17 2020-04-21 Farapulse, Inc. Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation
US10660702B2 (en) 2016-01-05 2020-05-26 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10687892B2 (en) 2018-09-20 2020-06-23 Farapulse, Inc. Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10702337B2 (en) 2016-06-27 2020-07-07 Galary, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US10722184B2 (en) 2014-11-17 2020-07-28 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10820941B2 (en) 2006-06-28 2020-11-03 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US10827977B2 (en) 2012-05-21 2020-11-10 Kardium Inc. Systems and methods for activating transducers
US10835314B2 (en) 2014-10-14 2020-11-17 Farapulse, Inc. Method and apparatus for rapid and safe pulmonary vein cardiac ablation
US10842572B1 (en) 2019-11-25 2020-11-24 Farapulse, Inc. Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines
US10893905B2 (en) 2017-09-12 2021-01-19 Farapulse, Inc. Systems, apparatuses, and methods for ventricular focal ablation
US11020180B2 (en) 2018-05-07 2021-06-01 Farapulse, Inc. Epicardial ablation catheter
US11033236B2 (en) 2018-05-07 2021-06-15 Farapulse, Inc. Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation
US11065047B2 (en) 2019-11-20 2021-07-20 Farapulse, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US11259869B2 (en) 2014-05-07 2022-03-01 Farapulse, Inc. Methods and apparatus for selective tissue ablation
US11389232B2 (en) 2006-06-28 2022-07-19 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US11426573B2 (en) 2012-08-09 2022-08-30 University Of Iowa Research Foundation Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region
US11497541B2 (en) 2019-11-20 2022-11-15 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US12042208B2 (en) 2018-05-03 2024-07-23 Boston Scientific Scimed, Inc. Systems, devices, and methods for ablation using surgical clamps
US12137968B2 (en) 2014-05-16 2024-11-12 Boston Scientific Scimed, Inc. Methods and apparatus for multi-catheter tissue ablation
US12144541B2 (en) 2016-01-05 2024-11-19 Boston Scientific Scimed, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US12150700B2 (en) 2015-08-06 2024-11-26 Medtronic, Inc. Cardiac pulsed field ablation
US12268437B2 (en) 2020-07-24 2025-04-08 Boston Scientific Scimed, Inc. Electric field application for single shot cardiac ablation by irreversible electroporation
US12295637B2 (en) 2018-02-08 2025-05-13 Boston Scientific Scimed, Inc. Method and apparatus for controlled delivery of pulsed electric field ablative energy to tissue
US12310652B2 (en) 2020-07-24 2025-05-27 Boston Scientific Scimed, Inc. Hybrid electroporation ablation catheter
US12343071B2 (en) 2021-01-27 2025-07-01 Boston Scientific Scimed, Inc Voltage controlled pulse sequences for irreversible electroporation ablations
US12349964B2 (en) 2020-09-30 2025-07-08 Boston Scientific Scimed, Inc. Pretreatment waveform for irreversible electroporation
US12403305B2 (en) 2016-06-27 2025-09-02 Galvanize Therapeutics, Inc. Immunostimulation in the treatment of viral infection

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190110704A1 (en) * 2017-10-06 2019-04-18 Symap Medical (Suzhou), Limited System and method for mapping the functional nerves innervating the wall of arteries, 3-d mapping and catheters for same
EP3399931B1 (en) * 2016-01-05 2022-04-06 Farapulse, Inc. System for delivery of ablative energy to tissue
US11737817B2 (en) 2016-04-18 2023-08-29 Boston Scientific Scimed, Inc. Methods and systems for controlling energy delivery in medical devices
EP3884895B1 (en) * 2016-11-29 2022-10-05 St. Jude Medical, Cardiology Division, Inc. Electroporation systems and catheters for electroporation systems
US10569081B2 (en) 2017-03-03 2020-02-25 Medtronic, Inc. Stacked potential electroporation
CN110461262B (en) * 2017-04-10 2023-01-06 圣犹达医疗用品心脏病学部门有限公司 Electroporation system and method of stimulating catheter
EP3459480A1 (en) * 2017-09-21 2019-03-27 National University of Ireland, Galway Apparatus for localising an electrical field
JP6778973B2 (en) * 2019-04-24 2020-11-04 株式会社Mitテクノロジー Drug administration device, its operation method, and supporter
US20200397505A1 (en) * 2019-06-19 2020-12-24 Farapulse, Inc. Systems, devices, and methods for focal ablation
US11540877B2 (en) * 2019-12-03 2023-01-03 Biosense Webster (Israel) Ltd. Pulse generator for irreversible electroporation
US20210169568A1 (en) * 2019-12-09 2021-06-10 Biosense Webster (Israel) Ltd. Oriented irreversible-electroporation (ire) pulses to compensate for cell size and orientation
US12076071B2 (en) 2020-08-14 2024-09-03 Kardium Inc. Systems and methods for treating tissue with pulsed field ablation
CR20230475A (en) 2021-04-07 2024-01-19 Btl Medical Dev A S Pulsed field ablation device and method
EP4366637B1 (en) 2021-07-06 2025-06-25 BTL Medical Development A.S. Pulsed field ablation device
CN113768612B (en) * 2021-07-30 2023-12-22 苏州艾科脉医疗技术有限公司 High voltage transmitting circuit for catheter and ablation instrument
CN119095544A (en) * 2022-04-26 2024-12-06 Crc Ep公司 Mapping and ablation system for linear pulsed field cardiac ablation
IL319700A (en) 2022-10-05 2025-05-01 Btl Medical Dev A S Pulsed field ablation device and method

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200104A (en) * 1977-11-17 1980-04-29 Valleylab, Inc. Contact area measurement apparatus for use in electrosurgery
US5242441A (en) * 1992-02-24 1993-09-07 Boaz Avitall Deflectable catheter with rotatable tip electrode
US5578040A (en) * 1994-06-14 1996-11-26 Smith; Albert C. Ocular repair system and apparatus
US5836874A (en) * 1996-04-08 1998-11-17 Ep Technologies, Inc. Multi-function electrode structures for electrically analyzing and heating body tissue
US5863291A (en) * 1996-04-08 1999-01-26 Cardima, Inc. Linear ablation assembly
US20030130711A1 (en) * 2001-09-28 2003-07-10 Pearson Robert M. Impedance controlled tissue ablation apparatus and method
US20040087939A1 (en) * 1993-05-10 2004-05-06 Arthrocare Corporation Methods for electrosurgical tissue treatment between spaced apart electrodes
US6805128B1 (en) * 1996-10-22 2004-10-19 Epicor Medical, Inc. Apparatus and method for ablating tissue
US20060293731A1 (en) * 2005-06-24 2006-12-28 Boris Rubinsky Methods and systems for treating tumors using electroporation
US20090062788A1 (en) * 2007-08-31 2009-03-05 Long Gary L Electrical ablation surgical instruments
US20090076500A1 (en) * 2007-09-14 2009-03-19 Lazure Technologies, Llc Multi-tine probe and treatment by activation of opposing tines
US20090138009A1 (en) * 2007-11-05 2009-05-28 Viswanathan Raju R Magnetically guided energy delivery apparatus
US20110130708A1 (en) * 2009-05-13 2011-06-02 Minnow Medical, Inc. Directional Delivery of Energy and Bioactives
US20120095459A1 (en) * 2010-10-13 2012-04-19 Peter Callas System and Method for Electrically Ablating Tissue of a Patient

Family Cites Families (561)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470407A (en) 1982-03-11 1984-09-11 Laserscope, Inc. Endoscopic device
US4739759A (en) 1985-02-26 1988-04-26 Concept, Inc. Microprocessor controlled electrosurgical generator
US5547467A (en) 1988-01-21 1996-08-20 Massachusettes Institute Of Technology Method for rapid temporal control of molecular transport across tissue
US5344435A (en) 1988-07-28 1994-09-06 Bsd Medical Corporation Urethral inserted applicator prostate hyperthermia
FR2639238B1 (en) 1988-11-21 1991-02-22 Technomed Int Sa APPARATUS FOR SURGICAL TREATMENT OF TISSUES BY HYPERTHERMIA, PREFERABLY THE PROSTATE, COMPRISING MEANS OF THERMAL PROTECTION COMPRISING PREFERABLY RADIOREFLECTIVE SCREEN MEANS
US5257635A (en) 1988-11-25 1993-11-02 Sensor Electronics, Inc. Electrical heating catheter
US5749914A (en) 1989-01-06 1998-05-12 Advanced Coronary Intervention Catheter for obstructed stent
US5342301A (en) 1992-08-13 1994-08-30 Advanced Polymers Incorporated Multi-lumen balloons and catheters made therewith
WO1992021285A1 (en) 1991-05-24 1992-12-10 Ep Technologies, Inc. Combination monophasic action potential/ablation catheter and high-performance filter system
US6029671A (en) 1991-07-16 2000-02-29 Heartport, Inc. System and methods for performing endovascular procedures
US5697281A (en) 1991-10-09 1997-12-16 Arthrocare Corporation System and method for electrosurgical cutting and ablation
US5524338A (en) 1991-10-22 1996-06-11 Pi Medical Corporation Method of making implantable microelectrode
US5304214A (en) 1992-01-21 1994-04-19 Med Institute, Inc. Transurethral ablation catheter
US5306296A (en) 1992-08-21 1994-04-26 Medtronic, Inc. Annuloplasty and suture rings
US5281213A (en) 1992-04-16 1994-01-25 Implemed, Inc. Catheter for ice mapping and ablation
US5443463A (en) 1992-05-01 1995-08-22 Vesta Medical, Inc. Coagulating forceps
US20050222632A1 (en) 1992-05-17 2005-10-06 Obino Stan F Device and method for the treatment of cardiac disorders
US5341807A (en) 1992-06-30 1994-08-30 American Cardiac Ablation Co., Inc. Ablation catheter positioning system
US5662108A (en) 1992-09-23 1997-09-02 Endocardial Solutions, Inc. Electrophysiology mapping system
US5313943A (en) 1992-09-25 1994-05-24 Ep Technologies, Inc. Catheters and methods for performing cardiac diagnosis and treatment
US5700243A (en) 1992-10-30 1997-12-23 Pdt Systems, Inc. Balloon perfusion catheter
US6068653A (en) 1992-11-13 2000-05-30 Scimed Life Systems, Inc. Electrophysiology catheter device
US5334193A (en) 1992-11-13 1994-08-02 American Cardiac Ablation Co., Inc. Fluid cooled ablation catheter
US5545161A (en) 1992-12-01 1996-08-13 Cardiac Pathways Corporation Catheter for RF ablation having cooled electrode with electrically insulated sleeve
US5531685A (en) 1993-06-11 1996-07-02 Catheter Research, Inc. Steerable variable stiffness device
FR2708860B1 (en) 1993-08-11 1995-10-13 Ela Medical Sa Protection circuit for implantable electronic device.
US5558091A (en) 1993-10-06 1996-09-24 Biosense, Inc. Magnetic determination of position and orientation
US5545193A (en) 1993-10-15 1996-08-13 Ep Technologies, Inc. Helically wound radio-frequency emitting electrodes for creating lesions in body tissue
US5722400A (en) 1995-02-16 1998-03-03 Daig Corporation Guiding introducers for use in the treatment of left ventricular tachycardia
US5454370A (en) 1993-12-03 1995-10-03 Avitall; Boaz Mapping and ablation electrode configuration
US5921924A (en) 1993-12-03 1999-07-13 Avitall; Boaz Mapping and ablation catheter system utilizing multiple control elements
US5928269A (en) 1994-04-04 1999-07-27 Alt; Eckhard Apparatus and method for temporary atrial defibrillation with external defibrillator and implanted transvenous catheter and electrodes
US5617854A (en) 1994-06-22 1997-04-08 Munsif; Anand Shaped catheter device and method
US5885278A (en) 1994-10-07 1999-03-23 E.P. Technologies, Inc. Structures for deploying movable electrode elements
US6071274A (en) 1996-12-19 2000-06-06 Ep Technologies, Inc. Loop structures for supporting multiple electrode elements
US5836947A (en) 1994-10-07 1998-11-17 Ep Technologies, Inc. Flexible structures having movable splines for supporting electrode elements
US5722402A (en) 1994-10-11 1998-03-03 Ep Technologies, Inc. Systems and methods for guiding movable electrode elements within multiple-electrode structures
US5876336A (en) 1994-10-11 1999-03-02 Ep Technologies, Inc. Systems and methods for guiding movable electrode elements within multiple-electrode structure
US5624430A (en) 1994-11-28 1997-04-29 Eton; Darwin Magnetic device to assist transcorporeal guidewire placement
US5647871A (en) 1995-03-10 1997-07-15 Microsurge, Inc. Electrosurgery with cooled electrodes
US5810762A (en) 1995-04-10 1998-09-22 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US20060024359A1 (en) 1995-06-07 2006-02-02 Walker Jeffrey P Drug delivery system and method
US6090104A (en) 1995-06-07 2000-07-18 Cordis Webster, Inc. Catheter with a spirally wound flat ribbon electrode
US5702438A (en) 1995-06-08 1997-12-30 Avitall; Boaz Expandable recording and ablation catheter system
US5788692A (en) 1995-06-30 1998-08-04 Fidus Medical Technology Corporation Mapping ablation catheter
US6023638A (en) 1995-07-28 2000-02-08 Scimed Life Systems, Inc. System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US5706823A (en) 1995-08-18 1998-01-13 Quinton Instrument Company Electrophysiology filtering system
JP3333520B2 (en) 1995-10-06 2002-10-15 コーディス ウェブスター,インコーポレイティド Split tip electrode catheter
DE29519651U1 (en) 1995-12-14 1996-02-01 Muntermann, Axel, 35583 Wetzlar Device for linear radio frequency catheter ablation of endomyocardial tissue
BR9612395A (en) 1995-12-29 1999-07-13 Gyrus Medical Ltd Electrosurgical instrument and an electrosurgical electrode set
US7141049B2 (en) 1999-03-09 2006-11-28 Thermage, Inc. Handpiece for treatment of tissue
US5868736A (en) 1996-04-12 1999-02-09 Ep Technologies, Inc. Systems and methods to control tissue heating or ablation with porous electrode structures
WO1997025917A1 (en) 1996-01-19 1997-07-24 Ep Technologies, Inc. Multi-function electrode structures for electrically analyzing and heating body tissue
US5800482A (en) 1996-03-06 1998-09-01 Cardiac Pathways Corporation Apparatus and method for linear lesion ablation
US5830224A (en) 1996-03-15 1998-11-03 Beth Israel Deaconess Medical Center Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo
US5779699A (en) 1996-03-29 1998-07-14 Medtronic, Inc. Slip resistant field focusing ablation catheter electrode
US5836942A (en) 1996-04-04 1998-11-17 Minnesota Mining And Manufacturing Company Biomedical electrode with lossy dielectric properties
US5904709A (en) 1996-04-17 1999-05-18 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microwave treatment for cardiac arrhythmias
US5672170A (en) 1996-06-20 1997-09-30 Cynosure, Inc. Laser transmyocardial revascularization arrangement
US6006131A (en) 1996-08-13 1999-12-21 Uab Research Foundation Dual current pathway atrial defibrillation apparatus
DE59610941D1 (en) 1996-09-27 2004-04-22 Sulzer Osypka Gmbh Device for performing diagnostic and / or therapeutic cardiac interventions with a catheter
US6464697B1 (en) 1998-02-19 2002-10-15 Curon Medical, Inc. Stomach and adjoining tissue regions in the esophagus
US6311692B1 (en) 1996-10-22 2001-11-06 Epicor, Inc. Apparatus and method for diagnosis and therapy of electrophysiological disease
US7052493B2 (en) 1996-10-22 2006-05-30 Epicor Medical, Inc. Methods and devices for ablation
US6096036A (en) 1998-05-05 2000-08-01 Cardiac Pacemakers, Inc. Steerable catheter with preformed distal shape and method for use
US6035238A (en) 1997-08-13 2000-03-07 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US6002955A (en) 1996-11-08 1999-12-14 Medtronic, Inc. Stabilized electrophysiology catheter and method for use
US6076012A (en) 1996-12-19 2000-06-13 Ep Technologies, Inc. Structures for supporting porous electrode elements
US5916213A (en) 1997-02-04 1999-06-29 Medtronic, Inc. Systems and methods for tissue mapping and ablation
US6039757A (en) 1997-03-12 2000-03-21 Cardiosynopsis, Inc. In situ formed fenestrated stent
US6223085B1 (en) 1997-05-06 2001-04-24 Urologix, Inc. Device and method for preventing restenosis
US6012457A (en) 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US5849028A (en) 1997-05-16 1998-12-15 Irvine Biomedical, Inc. Catheter and method for radiofrequency ablation of cardiac tissue
US5978704A (en) 1997-06-03 1999-11-02 Uab Research Foundation Method and apparatus for treating cardiac arrhythmia
US5938660A (en) 1997-06-27 1999-08-17 Daig Corporation Process and device for the treatment of atrial arrhythmia
US6164283A (en) 1997-07-08 2000-12-26 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6245064B1 (en) 1997-07-08 2001-06-12 Atrionix, Inc. Circumferential ablation device assembly
US6966908B2 (en) 1997-07-08 2005-11-22 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
ATE433306T1 (en) 1997-07-08 2009-06-15 Univ California DEVICE FOR CIRCUMFERENTIAL ABLATION
US6009351A (en) 1997-07-14 1999-12-28 Urologix, Inc. System and method for transurethral heating with rectal cooling
US6014579A (en) 1997-07-21 2000-01-11 Cardiac Pathways Corp. Endocardial mapping catheter with movable electrode
WO1999004851A1 (en) 1997-07-22 1999-02-04 Emed Corporation Iontophoretic delivery of an agent into cardiac tissue
US6216034B1 (en) * 1997-08-01 2001-04-10 Genetronics, Inc. Method of programming an array of needle electrodes for electroporation therapy of tissue
US6200312B1 (en) * 1997-09-11 2001-03-13 Vnus Medical Technologies, Inc. Expandable vein ligator catheter having multiple electrode leads
US5895404A (en) 1997-09-29 1999-04-20 Ruiz; Carlos E. Apparatus and methods for percutaneously forming a passageway between adjacent vessels or portions of a vessel
US6464699B1 (en) 1997-10-10 2002-10-15 Scimed Life Systems, Inc. Method and apparatus for positioning a diagnostic or therapeutic element on body tissue and mask element for use with same
US6071281A (en) 1998-05-05 2000-06-06 Ep Technologies, Inc. Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same
US6645200B1 (en) 1997-10-10 2003-11-11 Scimed Life Systems, Inc. Method and apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same
JP2001521774A (en) 1997-10-31 2001-11-13 シー・アール・バード・インコーポレーテッド Ring-shaped electrode structure for diagnostic and ablation catheters
US6120500A (en) 1997-11-12 2000-09-19 Daig Corporation Rail catheter ablation and mapping system
US5928270A (en) 1997-12-02 1999-07-27 Cardiocommand, Inc. Method and apparatus for incremental cardioversion or defibrillation
US6517534B1 (en) 1998-02-11 2003-02-11 Cosman Company, Inc. Peri-urethral ablation
DE19805530C1 (en) * 1998-02-11 1999-07-22 Marquette Hellige Gmbh Device for improving signals in an electrocardiogram (ECG) subject to frequent artefacts
US6447505B2 (en) 1998-02-11 2002-09-10 Cosman Company, Inc. Balloon catheter method for intra-urethral radio-frequency urethral enlargement
US20020095175A1 (en) 1998-02-24 2002-07-18 Brock David L. Flexible instrument
US6167291A (en) 1998-03-12 2000-12-26 Cardima, Inc. Protected pin connector for an electrophysiology catheter
DE19817553A1 (en) 1998-04-15 1999-10-21 Biotronik Mess & Therapieg Ablation arrangement
US6030384A (en) 1998-05-01 2000-02-29 Nezhat; Camran Bipolar surgical instruments having focused electrical fields
US6045550A (en) 1998-05-05 2000-04-04 Cardiac Peacemakers, Inc. Electrode having non-joined thermocouple for providing multiple temperature-sensitive junctions
US6171305B1 (en) * 1998-05-05 2001-01-09 Cardiac Pacemakers, Inc. RF ablation apparatus and method having high output impedance drivers
US6146381A (en) 1998-05-05 2000-11-14 Cardiac Pacemakers, Inc. Catheter having distal region for deflecting axial forces
US6592581B2 (en) 1998-05-05 2003-07-15 Cardiac Pacemakers, Inc. Preformed steerable catheter with movable outer sleeve and method for use
US6527767B2 (en) 1998-05-20 2003-03-04 New England Medical Center Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization
US6231518B1 (en) 1998-05-26 2001-05-15 Comedicus Incorporated Intrapericardial electrophysiological procedures
US6287306B1 (en) 1998-06-22 2001-09-11 Daig Corporation Even temperature linear lesion ablation catheter
US6251107B1 (en) 1998-06-25 2001-06-26 Cardima, Inc. Ep catheter
US6322559B1 (en) 1998-07-06 2001-11-27 Vnus Medical Technologies, Inc. Electrode catheter having coil structure
US6623480B1 (en) 1998-07-24 2003-09-23 University Of Kentucky Research Foundation Flexible recording/high energy electrode catheter with anchor for ablation of atrial flutter by radio frequency energy
US7435247B2 (en) 1998-08-11 2008-10-14 Arthrocare Corporation Systems and methods for electrosurgical tissue treatment
US6251128B1 (en) 1998-09-01 2001-06-26 Fidus Medical Technology Corporation Microwave ablation catheter with loop configuration
US8308719B2 (en) 1998-09-21 2012-11-13 St. Jude Medical, Atrial Fibrillation Division, Inc. Apparatus and method for ablating tissue
US6807447B2 (en) 1998-09-25 2004-10-19 Ep Medsystems, Inc. Triple array defibrillation catheter and method of using the same
US6033403A (en) 1998-10-08 2000-03-07 Irvine Biomedical, Inc. Long electrode catheter system and methods thereof
US6638278B2 (en) 1998-11-23 2003-10-28 C. R. Bard, Inc. Intracardiac grasp catheter
IT1302900B1 (en) 1998-12-04 2000-10-10 Riccardo Fenici AMAGNETIC CATHETER FOR THE SINGLE-CATHETER REGISTRATION OF MULTIPLE SINGLE-PHASE ACTION POTENTIALS, LOCABLE THREE-DIMENSIONALLY AND
US20070066972A1 (en) 2001-11-29 2007-03-22 Medwaves, Inc. Ablation catheter apparatus with one or more electrodes
US6219582B1 (en) 1998-12-30 2001-04-17 Daig Corporation Temporary atrial cardioversion catheter
US6206831B1 (en) 1999-01-06 2001-03-27 Scimed Life Systems, Inc. Ultrasound-guided ablation catheter and methods of use
US20010007070A1 (en) 1999-04-05 2001-07-05 Medtronic, Inc. Ablation catheter assembly and method for isolating a pulmonary vein
US6325797B1 (en) 1999-04-05 2001-12-04 Medtronic, Inc. Ablation catheter and method for isolating a pulmonary vein
US6702811B2 (en) 1999-04-05 2004-03-09 Medtronic, Inc. Ablation catheter assembly with radially decreasing helix and method of use
US6270476B1 (en) 1999-04-23 2001-08-07 Cryocath Technologies, Inc. Catheter
US6272384B1 (en) 1999-05-27 2001-08-07 Urologix, Inc. Microwave therapy apparatus
US7171263B2 (en) 1999-06-04 2007-01-30 Impulse Dynamics Nv Drug delivery device
US6391024B1 (en) 1999-06-17 2002-05-21 Cardiac Pacemakers, Inc. RF ablation apparatus and method having electrode/tissue contact assessment scheme and electrocardiogram filtering
US6300108B1 (en) 1999-07-21 2001-10-09 The Regents Of The University Of California Controlled electroporation and mass transfer across cell membranes
DE19938558A1 (en) 1999-08-17 2001-02-22 Axel Muntermann Catheters with improved electrical properties and treatment methods for improving the electrical properties of catheters
US6607520B2 (en) 1999-09-15 2003-08-19 The General Hospital Corporation Coiled ablation catheter system
US6370412B1 (en) 1999-10-07 2002-04-09 Massachusetts Institute Of Technology Method and apparatus for guiding ablative therapy of abnormal biological electrical excitation
US6613062B1 (en) 1999-10-29 2003-09-02 Medtronic, Inc. Method and apparatus for providing intra-pericardial access
US6529756B1 (en) 1999-11-22 2003-03-04 Scimed Life Systems, Inc. Apparatus for mapping and coagulating soft tissue in or around body orifices
US6892091B1 (en) 2000-02-18 2005-05-10 Biosense, Inc. Catheter, method and apparatus for generating an electrical map of a chamber of the heart
DE10008918A1 (en) 2000-02-25 2001-08-30 Biotronik Mess & Therapieg Ablation catheter to create linear lesions in cardiac muscle tissue
WO2001072368A2 (en) 2000-03-31 2001-10-04 Medtronic, Inc. Intralumenal visualization system with deflectable mechanism
US7497844B2 (en) 2000-03-31 2009-03-03 Medtronic, Inc. System and method for positioning implantable medical devices within coronary veins
US6652517B1 (en) 2000-04-25 2003-11-25 Uab Research Foundation Ablation catheter, system, and method of use thereof
US6932811B2 (en) 2000-04-27 2005-08-23 Atricure, Inc. Transmural ablation device with integral EKG sensor
US6546935B2 (en) 2000-04-27 2003-04-15 Atricure, Inc. Method for transmural ablation
US20020107514A1 (en) 2000-04-27 2002-08-08 Hooven Michael D. Transmural ablation device with parallel jaws
US6743239B1 (en) 2000-05-25 2004-06-01 St. Jude Medical, Inc. Devices with a bendable tip for medical procedures
JP2004520865A (en) 2000-07-25 2004-07-15 リタ メディカル システムズ インコーポレイテッド Apparatus for tumor detection and treatment using localized impedance measurements
US8251986B2 (en) 2000-08-17 2012-08-28 Angiodynamics, Inc. Method of destroying tissue cells by eletroporation
US6728563B2 (en) 2000-11-29 2004-04-27 St. Jude Medical, Daig Division, Inc. Electrophysiology/ablation catheter having “halo” configuration
US7081114B2 (en) 2000-11-29 2006-07-25 St. Jude Medical, Atrial Fibrillation Division, Inc. Electrophysiology/ablation catheter having lariat configuration of variable radius
AU2002248196A1 (en) 2000-12-15 2002-08-12 Tony R. Brown Atrial fibrillation rf treatment device and method
US6620157B1 (en) 2000-12-28 2003-09-16 Senorx, Inc. High frequency power source
DE10102089C1 (en) 2001-01-18 2002-07-25 Wolf Gmbh Richard Surgical instrument
DE10102254A1 (en) 2001-01-19 2002-08-08 Celon Ag Medical Instruments Device for the electrothermal treatment of the human or animal body
US6743226B2 (en) 2001-02-09 2004-06-01 Cosman Company, Inc. Adjustable trans-urethral radio-frequency ablation
US7229402B2 (en) 2001-02-09 2007-06-12 Cardiac Output Technologies, Inc. Minimally invasive ventricular assist technology and method
US7137975B2 (en) 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
US6666863B2 (en) 2001-03-01 2003-12-23 Scimed Life Systems, Inc. Device and method for percutaneous myocardial revascularization
US6666862B2 (en) 2001-03-01 2003-12-23 Cardiac Pacemakers, Inc. Radio frequency ablation system and method linking energy delivery with fluid flow
US6743225B2 (en) 2001-03-27 2004-06-01 Uab Research Foundation Electrophysiologic measure of endpoints for ablation lesions created in fibrillating substrates
US6619291B2 (en) 2001-04-24 2003-09-16 Edwin J. Hlavka Method and apparatus for catheter-based annuloplasty
WO2002087676A2 (en) 2001-04-27 2002-11-07 C.R. Bard, Inc. Electrophysiology catheter for mapping and/or ablation
US6972016B2 (en) 2001-05-01 2005-12-06 Cardima, Inc. Helically shaped electrophysiology catheter
US6771996B2 (en) 2001-05-24 2004-08-03 Cardiac Pacemakers, Inc. Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination
US6685702B2 (en) 2001-07-06 2004-02-03 Rodolfo C. Quijano Device for treating tissue and methods thereof
US20030018374A1 (en) 2001-07-16 2003-01-23 Paulos Lonnie E. Treatment probe using RF energy
US6994706B2 (en) 2001-08-13 2006-02-07 Minnesota Medical Physics, Llc Apparatus and method for treatment of benign prostatic hyperplasia
US8623012B2 (en) 2001-08-15 2014-01-07 Nuortho Surgical, Inc. Electrosurgical plenum
JP2005532832A (en) 2001-09-24 2005-11-04 ノヴォスト コーポレイション Method and apparatus using ionizing radiation for the treatment of arrhythmias
US7285116B2 (en) 2004-05-15 2007-10-23 Irvine Biomedical Inc. Non-contact tissue ablation device and methods thereof
US8175680B2 (en) 2001-11-09 2012-05-08 Boston Scientific Scimed, Inc. Systems and methods for guiding catheters using registered images
US6669693B2 (en) 2001-11-13 2003-12-30 Mayo Foundation For Medical Education And Research Tissue ablation device and methods of using
US7542807B2 (en) 2001-12-04 2009-06-02 Endoscopic Technologies, Inc. Conduction block verification probe and method of use
US6740084B2 (en) 2001-12-18 2004-05-25 Ethicon, Inc. Method and device to enhance RF electrode performance
EP1465555B1 (en) 2001-12-21 2015-05-06 QuickRing Medical Technologies Ltd. Implantation system for annuloplasty rings
US7493156B2 (en) 2002-01-07 2009-02-17 Cardiac Pacemakers, Inc. Steerable guide catheter with pre-shaped rotatable shaft
US8062251B2 (en) 2002-02-01 2011-11-22 Vascular Designs, Inc. Multi-function catheter and use thereof
US6926714B1 (en) 2002-02-05 2005-08-09 Jasbir S. Sra Method for pulmonary vein isolation and catheter ablation of other structures in the left atrium in atrial fibrillation
US6932816B2 (en) 2002-02-19 2005-08-23 Boston Scientific Scimed, Inc. Apparatus for converting a clamp into an electrophysiology device
US6733499B2 (en) 2002-02-28 2004-05-11 Biosense Webster, Inc. Catheter having circular ablation assembly
US6869414B2 (en) 2002-03-22 2005-03-22 Cardiac Pacemakers, Inc. Pre-shaped catheter with proximal articulation and pre-formed distal end
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US8774913B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravasculary-induced neuromodulation
US6764486B2 (en) 2002-04-24 2004-07-20 Biotronik Mess- und Therapieger{haeck over (a)}te GmbH & Co. Ingenieurbüro Berlin Ablation device for cardiac tissue, especially for forming a circular lesion around a vessel orifice in the heart
DE10218427A1 (en) 2002-04-24 2003-11-06 Biotronik Mess & Therapieg Ablation device for cardiac tissue, in particular for creating a circular lesion around a vascular mouth in the heart
US20030204161A1 (en) 2002-04-25 2003-10-30 Bozidar Ferek-Petric Implantable electroporation therapy device and method for using same
US6780178B2 (en) 2002-05-03 2004-08-24 The Board Of Trustees Of The Leland Stanford Junior University Method and apparatus for plasma-mediated thermo-electrical ablation
US8216219B2 (en) * 2002-05-27 2012-07-10 Celon Ag Device for electrosurgically destroying body tissue
US20030229379A1 (en) 2002-06-06 2003-12-11 Maynard Ramsey Method for cardioversion or defibrillation using electrical impulses at pacing strength
US7367974B2 (en) 2004-09-20 2008-05-06 Wisconsin Alumni Research Foundation Electrode array for tissue ablation
US20040082859A1 (en) 2002-07-01 2004-04-29 Alan Schaer Method and apparatus employing ultrasound energy to treat body sphincters
US7001383B2 (en) 2002-10-21 2006-02-21 Biosense, Inc. Real-time monitoring and mapping of ablation lesion formation in the heart
US20040082947A1 (en) 2002-10-25 2004-04-29 The Regents Of The University Of Michigan Ablation catheters
US9730100B2 (en) 2002-10-28 2017-08-08 MeshDynamics Terse message networks
US9819747B2 (en) 2008-11-24 2017-11-14 MeshDynamics Chirp networks
EP1562506B1 (en) 2002-11-15 2009-05-13 C.R.Bard, Inc. Electrophysiology catheter with ablation electrode
WO2004045672A2 (en) 2002-11-15 2004-06-03 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services Variable curve catheter
US7195628B2 (en) 2002-12-11 2007-03-27 St. Jude Medical, Atrial Fibrillation Division, Inc. Atrial fibrillation therapy with pulmonary vein support
EP1585574A4 (en) 2002-12-20 2006-04-26 Cardiac Inv S Unltd Inc Apparatus and method for implanting left ventricular pacing leads within the coronary sinus
US6984232B2 (en) 2003-01-17 2006-01-10 St. Jude Medical, Daig Division, Inc. Ablation catheter assembly having a virtual electrode comprising portholes
US8192425B2 (en) 2006-09-29 2012-06-05 Baylis Medical Company Inc. Radiofrequency perforation apparatus
US6960207B2 (en) 2003-01-21 2005-11-01 St Jude Medical, Daig Division, Inc. Ablation catheter having a virtual electrode comprising portholes and a porous conductor
US7387629B2 (en) 2003-01-21 2008-06-17 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter design that facilitates positioning at tissue to be diagnosed or treated
US7622172B2 (en) 2003-02-19 2009-11-24 Erick Keenan Composite flexible and conductive catheter electrode
WO2004086994A1 (en) 2003-03-28 2004-10-14 C.R. Bard, Inc. Method and apparatus for electrosurgical ablation
US6985776B2 (en) 2003-04-25 2006-01-10 Medtronic, Inc. Method and apparatus for coronary sinus cannulation
US6980843B2 (en) 2003-05-21 2005-12-27 Stereotaxis, Inc. Electrophysiology catheter
US7163537B2 (en) 2003-06-02 2007-01-16 Biosense Webster, Inc. Enhanced ablation and mapping catheter and method for treating atrial fibrillation
US7044946B2 (en) 2003-06-10 2006-05-16 Cryocath Technologies Inc. Surgical clamp having treatment elements
US7540853B2 (en) 2003-06-30 2009-06-02 Cardiac Pacemakers, Inc. Method and apparatus for diverting blood flow during ablation procedures
US6973339B2 (en) 2003-07-29 2005-12-06 Biosense, Inc Lasso for pulmonary vein mapping and ablation
US20060009755A1 (en) 2003-09-04 2006-01-12 Sra Jasbir S Method and system for ablation of atrial fibrillation and other cardiac arrhythmias
US8147486B2 (en) 2003-09-22 2012-04-03 St. Jude Medical, Atrial Fibrillation Division, Inc. Medical device with flexible printed circuit
US7229437B2 (en) 2003-09-22 2007-06-12 St. Jude Medical, Atrial Fibrillation Division, Inc. Medical device having integral traces and formed electrodes
US7435248B2 (en) 2003-09-26 2008-10-14 Boston Scientific Scimed, Inc. Medical probes for creating and diagnosing circumferential lesions within or around the ostium of a vessel
US7179256B2 (en) 2003-10-24 2007-02-20 Biosense Webster, Inc. Catheter with ablation needle and mapping assembly
US7207989B2 (en) 2003-10-27 2007-04-24 Biosense Webster, Inc. Method for ablating with needle electrode
FR2861997A1 (en) 2003-11-06 2005-05-13 Fred Zacouto Cardiac muscle stimulation device e.g. defibrillator, for use during tachycardia treatment, has impulse generator that sends stimulation pulse without delay at end of refractory period
US7666203B2 (en) 2003-11-06 2010-02-23 Nmt Medical, Inc. Transseptal puncture apparatus
WO2005053555A1 (en) 2003-12-01 2005-06-16 Biotronik Crm Patent Ag Electrode catheter for the electrotherapy of cardiac tissue
US8048067B2 (en) 2003-12-24 2011-11-01 The Regents Of The University Of California Tissue ablation with irreversible electroporation
US20050187545A1 (en) * 2004-02-20 2005-08-25 Hooven Michael D. Magnetic catheter ablation device and method
WO2005087128A1 (en) 2004-03-05 2005-09-22 Hansen Medical, Inc. Robotic catheter system
US20060100610A1 (en) 2004-03-05 2006-05-11 Wallace Daniel T Methods using a robotic catheter system
US8548583B2 (en) 2004-03-10 2013-10-01 Impulse Dynamics Nv Protein activity modification
US7282057B2 (en) 2004-03-30 2007-10-16 Wilson-Cook Medical, Inc. Pediatric atresia magnets
US20050261672A1 (en) 2004-05-18 2005-11-24 Mark Deem Systems and methods for selective denervation of heart dysrhythmias
US7250049B2 (en) 2004-05-27 2007-07-31 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation catheter with suspension system incorporating rigid and flexible components
EP1750607A2 (en) 2004-06-02 2007-02-14 Medtronic, Inc. Loop ablation apparatus and method
US7527625B2 (en) 2004-08-04 2009-05-05 Olympus Corporation Transparent electrode for the radiofrequency ablation of tissue
US7556627B2 (en) 2004-09-13 2009-07-07 Ethicon Endo-Surgery, Inc. Mucosal ablation device
US7282049B2 (en) 2004-10-08 2007-10-16 Sherwood Services Ag Electrosurgical system employing multiple electrodes and method thereof
US20060089637A1 (en) 2004-10-14 2006-04-27 Werneth Randell L Ablation catheter
FR2877207B1 (en) 2004-10-29 2007-02-23 Jacques Hamou DEVICE FOR RESECTING ORGANIC TISSUE USED IN PARTICULAR IN UROLOGY OR HYSTEROSCOPY
US8409191B2 (en) 2004-11-04 2013-04-02 Boston Scientific Scimed, Inc. Preshaped ablation catheter for ablating pulmonary vein ostia within the heart
US7468062B2 (en) 2004-11-24 2008-12-23 Ablation Frontiers, Inc. Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use
US7429261B2 (en) 2004-11-24 2008-09-30 Ablation Frontiers, Inc. Atrial ablation catheter and method of use
US7731715B2 (en) 2004-12-10 2010-06-08 Edwards Lifesciences Corporation Ablative treatment of atrial fibrillation via the coronary sinus
US7869865B2 (en) 2005-01-07 2011-01-11 Biosense Webster, Inc. Current-based position sensing
US20070225589A1 (en) 2005-01-11 2007-09-27 Viswanathan Raju R Single catheter diagnosis, navigation and treatment of arrhythmias
RU2401067C2 (en) 2005-01-31 2010-10-10 Конинклейке Филипс Электроникс Н.В. Catheter guide wire and guiding technique in electrophysiological examinations
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
EP1874211B1 (en) * 2005-04-21 2017-05-31 Boston Scientific Scimed, Inc. Control devices for energy delivery
US7588567B2 (en) 2005-04-22 2009-09-15 Abl Technologies, Llc Method and system of stopping energy delivery of an ablation procedure with a computer based device for increasing safety of ablation procedures
US7578816B2 (en) 2005-04-22 2009-08-25 Abl Technologies, Llc Method and system of increasing safety of cardiac ablation procedures
US7512447B2 (en) 2005-04-25 2009-03-31 Medtronic, Inc. Medical electrical electrodes with conductive polymer
US20060264752A1 (en) 2005-04-27 2006-11-23 The Regents Of The University Of California Electroporation controlled with real time imaging
US8571635B2 (en) 2005-04-28 2013-10-29 Boston Scientific Scimed, Inc. Automated activation/deactivation of imaging device based on tracked medical device position
US8932208B2 (en) 2005-05-26 2015-01-13 Maquet Cardiovascular Llc Apparatus and methods for performing minimally-invasive surgical procedures
US20060270900A1 (en) 2005-05-26 2006-11-30 Chin Albert K Apparatus and methods for performing ablation
US9861836B2 (en) 2005-06-16 2018-01-09 Biosense Webster, Inc. Less invasive methods for ablation of fat pads
EP2759276A1 (en) 2005-06-20 2014-07-30 Medtronic Ablation Frontiers LLC Ablation catheter
US20060293730A1 (en) 2005-06-24 2006-12-28 Boris Rubinsky Methods and systems for treating restenosis sites using electroporation
US20070005053A1 (en) 2005-06-30 2007-01-04 Dando Jeremy D Ablation catheter with contoured openings in insulated electrodes
EP1907042B1 (en) 2005-07-06 2009-03-11 Vascular Pathways Inc. Intravenous catheter insertion device and method of use
US20070021744A1 (en) 2005-07-07 2007-01-25 Creighton Francis M Iv Apparatus and method for performing ablation with imaging feedback
AU2006268238A1 (en) 2005-07-11 2007-01-18 Medtronic Ablation Frontiers Llc Low power tissue ablation system
ITBO20050495A1 (en) 2005-07-22 2007-01-23 Fiab Spa EXOGUE PIPELINE
US7681579B2 (en) 2005-08-02 2010-03-23 Biosense Webster, Inc. Guided procedures for treating atrial fibrillation
US7416552B2 (en) 2005-08-22 2008-08-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation
US8657814B2 (en) 2005-08-22 2014-02-25 Medtronic Ablation Frontiers Llc User interface for tissue ablation system
JP2009506873A (en) 2005-09-07 2009-02-19 ザ ファウンドリー, インコーポレイテッド Apparatus and method for disrupting subcutaneous structures
US7623899B2 (en) 2005-09-16 2009-11-24 Biosense Webster, Inc. Catheter with flexible pre-shaped tip section
WO2007063443A2 (en) 2005-12-02 2007-06-07 Koninklijke Philips Electronics, N.V. Automating the ablation procedure to minimize the need for manual intervention
US8603084B2 (en) 2005-12-06 2013-12-10 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing the formation of a lesion in tissue
US8403925B2 (en) 2006-12-06 2013-03-26 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing lesions in tissue
US10362959B2 (en) 2005-12-06 2019-07-30 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing the proximity of an electrode to tissue in a body
US8406866B2 (en) 2005-12-06 2013-03-26 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing coupling between an electrode and tissue
US8449535B2 (en) 2005-12-06 2013-05-28 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for assessing coupling between an electrode and tissue
US9492226B2 (en) 2005-12-06 2016-11-15 St. Jude Medical, Atrial Fibrillation Division, Inc. Graphical user interface for real-time RF lesion depth display
WO2007076045A2 (en) 2005-12-24 2007-07-05 Crossman Arthur W Circumferential ablation guide wire system and related method of using the same
US7857809B2 (en) 2005-12-30 2010-12-28 Biosense Webster, Inc. Injection molded irrigated tip electrode and catheter having the same
US7879029B2 (en) 2005-12-30 2011-02-01 Biosense Webster, Inc. System and method for selectively energizing catheter electrodes
US20070167740A1 (en) 2005-12-30 2007-07-19 Grunewald Debby E Magnetic stabilization of catheter location sensor
JP4855482B2 (en) 2005-12-30 2012-01-18 シー・アール・バード・インコーポレーテッド Method and apparatus for exfoliating heart tissue
US20070156135A1 (en) 2006-01-03 2007-07-05 Boris Rubinsky System and methods for treating atrial fibrillation using electroporation
US7513896B2 (en) 2006-01-24 2009-04-07 Covidien Ag Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling
US7374567B2 (en) 2006-01-25 2008-05-20 Heuser Richard R Catheter system for connecting adjacent blood vessels
US7918850B2 (en) 2006-02-17 2011-04-05 Biosense Wabster, Inc. Lesion assessment by pacing
EP2007466A4 (en) 2006-03-31 2012-01-18 Automated Medical Instr Inc System and method for advancing, orienting, and immobilizing on internal body tissue a catheter or other therapeutic device
US7615044B2 (en) 2006-05-03 2009-11-10 Greatbatch Ltd. Deflectable sheath handle assembly and method therefor
WO2007134039A2 (en) 2006-05-08 2007-11-22 Medeikon Corporation Interferometric characterization of ablated tissue
US20140276782A1 (en) 2013-03-15 2014-09-18 Larry D. Paskar Catheter system
US7729752B2 (en) 2006-06-13 2010-06-01 Rhythmia Medical, Inc. Non-contact cardiac mapping, including resolution map
US7515954B2 (en) 2006-06-13 2009-04-07 Rhythmia Medical, Inc. Non-contact cardiac mapping, including moving catheter and multi-beat integration
US7783352B1 (en) 2006-06-23 2010-08-24 Pacesetter, Inc. Optimizing anti-tachycardia pacing for terminating atrial fibrillation
US8920411B2 (en) 2006-06-28 2014-12-30 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US9119633B2 (en) 2006-06-28 2015-09-01 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US8328752B2 (en) 2006-06-30 2012-12-11 Cvdevices, Llc Devices, systems, and methods for promotion of infarct healing and reinforcement of border zone
US8048072B2 (en) 2006-07-12 2011-11-01 Les Hospitaux Universitaires de Geneva Medical device for tissue ablation
US20080033426A1 (en) 2006-07-27 2008-02-07 Machell Charles H Catheter system and method of use thereof
US8273081B2 (en) 2006-09-08 2012-09-25 Stereotaxis, Inc. Impedance-based cardiac therapy planning method with a remote surgical navigation system
CA2666529A1 (en) 2006-10-13 2008-04-24 Apnex Medical, Inc. Obstructive sleep apnea treatment devices, systems and methods
AU2007231704B2 (en) 2006-11-29 2011-02-24 Cathrx Ltd Heat treating a biological site in a patient's body
US20080132885A1 (en) 2006-12-01 2008-06-05 Boris Rubinsky Methods for treating tissue sites using electroporation
US20080132884A1 (en) 2006-12-01 2008-06-05 Boris Rubinsky Systems for treating tissue sites using electroporation
EP2097762A1 (en) 2006-12-22 2009-09-09 Philips Intellectual Property & Standards GmbH Transmission line for use in magnetic resonance system
US8449537B2 (en) 2006-12-29 2013-05-28 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation catheter with thermally mediated catheter body for mitigating blood coagulation and creating larger lesion
US8226648B2 (en) 2007-12-31 2012-07-24 St. Jude Medical, Atrial Fibrillation Division, Inc. Pressure-sensitive flexible polymer bipolar electrode
US7883508B2 (en) 2006-12-29 2011-02-08 St. Jude Medical, Atrial Fibrillation Division, Inc. Contact-sensitive pressure-sensitive conductive composite electrode and method for ablation
US8108069B2 (en) 2007-01-10 2012-01-31 Hansen Medical, Inc. Robotic catheter system and methods
US9924998B2 (en) 2007-01-12 2018-03-27 Atricure, Inc. Ablation system, clamp and method of use
US20080200913A1 (en) 2007-02-07 2008-08-21 Viswanathan Raju R Single Catheter Navigation for Diagnosis and Treatment of Arrhythmias
US7655004B2 (en) 2007-02-15 2010-02-02 Ethicon Endo-Surgery, Inc. Electroporation ablation apparatus, system, and method
WO2008118737A1 (en) 2007-03-22 2008-10-02 University Of Virginia Patent Foundation Electrode catheter for ablation purposes and related method thereof
US11058354B2 (en) 2007-03-19 2021-07-13 University Of Virginia Patent Foundation Access needle with direct visualization and related methods
US9468396B2 (en) 2007-03-19 2016-10-18 University Of Virginia Patent Foundation Systems and methods for determining location of an access needle in a subject
EP2136702B1 (en) 2007-03-26 2015-07-01 Boston Scientific Limited High resolution electrophysiology catheter
US8597288B2 (en) 2008-10-01 2013-12-03 St. Jude Medical, Artial Fibrillation Division, Inc. Vacuum-stabilized ablation system
WO2008147603A2 (en) 2007-04-19 2008-12-04 S.D.M.H.Pty. Ltd. Devices and methods for thermal ablation of biological tissue using geometric ablation patterns
EP3391844A1 (en) 2007-04-19 2018-10-24 Miramar Labs, Inc. Apparatus for reducing sweat production
US8588885B2 (en) 2007-05-09 2013-11-19 St. Jude Medical, Atrial Fibrillation Division, Inc. Bendable catheter arms having varied flexibility
US8224416B2 (en) 2007-05-09 2012-07-17 St. Jude Medical, Atrial Fibrillation Division, Inc. Basket catheter having multiple electrodes
US8641704B2 (en) 2007-05-11 2014-02-04 Medtronic Ablation Frontiers Llc Ablation therapy system and method for treating continuous atrial fibrillation
US8100900B2 (en) 2007-05-11 2012-01-24 Board Of Trustees Of The Leland Stanford Junior University System for delivering therapy
US8216221B2 (en) 2007-05-21 2012-07-10 Estech, Inc. Cardiac ablation systems and methods
US7742810B2 (en) 2007-05-23 2010-06-22 Boston Scientific Neuromodulation Corporation Short duration pre-pulsing to reduce stimulation-evoked side-effects
US10220187B2 (en) 2010-06-16 2019-03-05 St. Jude Medical, Llc Ablation catheter having flexible tip with multiple flexible electrode segments
US8160690B2 (en) 2007-06-14 2012-04-17 Hansen Medical, Inc. System and method for determining electrode-tissue contact based on amplitude modulation of sensed signal
US20090024084A1 (en) 2007-07-16 2009-01-22 Peritec Biosciences Ltd. Multi-lumen catheter assembly and method of providing relative motion thereto
US20090076502A1 (en) 2007-09-14 2009-03-19 Lazure Technologies, Llc. Prostate cancer ablation
US20090118726A1 (en) 2007-10-05 2009-05-07 Coaptus Medical Corporation Systems and Methods for Transeptal Cardiac Procedures, Including Tissue Sealing Members Associated Methods
US8500697B2 (en) 2007-10-19 2013-08-06 Pressure Products Medical Supplies, Inc. Transseptal guidewire
US20100241185A1 (en) 2007-11-09 2010-09-23 University Of Virginia Patent Foundation Steerable epicardial pacing catheter system placed via the subxiphoid process
US8906011B2 (en) 2007-11-16 2014-12-09 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US9717501B2 (en) 2007-11-21 2017-08-01 St. Jude Medical, Atrial Fibrillation Division, Inc. Methods and systems for occluding vessels during cardiac ablation including optional electroanatomical guidance
US9452288B2 (en) * 2007-12-06 2016-09-27 Boston Scientific Neuromodulation Corporation Multimodal neurostimulation systems and methods
WO2009082710A1 (en) 2007-12-21 2009-07-02 Endometabolic Solutions, Inc. Methods and devices for endoscopically creating an anastomosis
US8353907B2 (en) 2007-12-21 2013-01-15 Atricure, Inc. Ablation device with internally cooled electrodes
US8562600B2 (en) 2007-12-27 2013-10-22 St. Jude Medical, Atrial Fibrillation Division, Inc. Integration of control software with a medical device and system
US9204927B2 (en) 2009-05-13 2015-12-08 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for presenting information representative of lesion formation in tissue during an ablation procedure
EP2231002A1 (en) 2008-01-09 2010-09-29 Mayo Foundation for Medical Education and Research Mapping and ablation catheter system
WO2009092059A2 (en) 2008-01-16 2009-07-23 Catheter Robotics, Inc. Remotely controlled catheter insertion system
US8235988B2 (en) 2008-01-24 2012-08-07 Coherex Medical, Inc. Systems and methods for reduction of atrial fibrillation
US8617145B2 (en) 2008-01-25 2013-12-31 Intrepid Medical, Inc. Methods of treating a cardiac arrhythmia by thoracoscopic production of a Cox maze III lesion set
US20090228003A1 (en) 2008-03-04 2009-09-10 Prorhythm, Inc. Tissue ablation device using radiofrequency and high intensity focused ultrasound
EP2252226B1 (en) 2008-03-12 2017-11-15 AFreeze GmbH Ablation system
US20100004623A1 (en) 2008-03-27 2010-01-07 Angiodynamics, Inc. Method for Treatment of Complications Associated with Arteriovenous Grafts and Fistulas Using Electroporation
US8538509B2 (en) 2008-04-02 2013-09-17 Rhythmia Medical, Inc. Intracardiac tracking system
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US8926606B2 (en) 2009-04-09 2015-01-06 Virginia Tech Intellectual Properties, Inc. Integration of very short electric pulses for minimally to noninvasive electroporation
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
WO2009137800A2 (en) 2008-05-09 2009-11-12 Angiodynamics, Inc. Electroporation device and method
US9474574B2 (en) 2008-05-21 2016-10-25 Atricure, Inc. Stabilized ablation systems and methods
US20090306651A1 (en) 2008-06-09 2009-12-10 Clint Schneider Catheter assembly with front-loaded tip
US8206385B2 (en) 2008-06-09 2012-06-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter assembly with front-loaded tip and multi-contact connector
US20100010484A1 (en) * 2008-07-14 2010-01-14 Primaeva Medical, Inc. Devices and methods for percutaneous energy delivery
EP2317952A1 (en) 2008-07-17 2011-05-11 Maestroheart SA Medical device for tissue ablation
US8585695B2 (en) 2008-07-22 2013-11-19 Hue-Teh Shih Systems and methods for noncontact ablation
US8221411B2 (en) 2008-07-28 2012-07-17 Medtronic, Inc. Systems and methods for cardiac tissue electroporation ablation
JP4545210B2 (en) 2008-09-11 2010-09-15 日本ライフライン株式会社 Defibrillation catheter
US20100100093A1 (en) * 2008-09-16 2010-04-22 Lazure Technologies, Llc. System and method for controlled tissue heating for destruction of cancerous cells
US9119533B2 (en) 2008-10-07 2015-09-01 Mc10, Inc. Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy
US8808281B2 (en) 2008-10-21 2014-08-19 Microcube, Llc Microwave treatment devices and methods
US8137343B2 (en) 2008-10-27 2012-03-20 Rhythmia Medical, Inc. Tracking system using field mapping
US9220924B2 (en) 2008-10-30 2015-12-29 Vytronus, Inc. System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion
US8414508B2 (en) 2008-10-30 2013-04-09 Vytronus, Inc. System and method for delivery of energy to tissue while compensating for collateral tissue
US9192789B2 (en) 2008-10-30 2015-11-24 Vytronus, Inc. System and method for anatomical mapping of tissue and planning ablation paths therein
US9192769B2 (en) 2008-10-31 2015-11-24 Medtronic, Inc. Shunt-current reduction techniques for an implantable therapy system
US9795442B2 (en) 2008-11-11 2017-10-24 Shifamed Holdings, Llc Ablation catheters
US8475445B2 (en) 2008-12-01 2013-07-02 Daniel Soroff Spectral analysis of intracardiac electrograms to predict identification of radiofrequency ablation sites
US8475450B2 (en) 2008-12-30 2013-07-02 Biosense Webster, Inc. Dual-purpose lasso catheter with irrigation
US8361066B2 (en) 2009-01-12 2013-01-29 Ethicon Endo-Surgery, Inc. Electrical ablation devices
US20100191232A1 (en) 2009-01-27 2010-07-29 Boveda Marco Medical Llc Catheters and methods for performing electrophysiological interventions
US8231603B2 (en) 2009-02-10 2012-07-31 Angiodynamics, Inc. Irreversible electroporation and tissue regeneration
WO2010093603A1 (en) 2009-02-11 2010-08-19 Boston Scientific Scimed, Inc. Insulated ablation catheter devices and methods of use
WO2010091701A1 (en) 2009-02-12 2010-08-19 Umc Utrecht Holding B.V. Ablation catheter and method for electrically isolating cardiac tissue
WO2010096347A1 (en) 2009-02-20 2010-08-26 Boston Scientific Scimed, Inc. Asymmetric dual directional steerable catheter sheath
US8747297B2 (en) 2009-03-02 2014-06-10 Olympus Corporation Endoscopic heart surgery method
WO2010117806A1 (en) 2009-03-31 2010-10-14 Angiodynamics, Inc. System and method for estimating a treatment region for a medical treatment device and for interactively planning a treatment of a patient
US8632534B2 (en) 2009-04-03 2014-01-21 Angiodynamics, Inc. Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US8287532B2 (en) 2009-04-13 2012-10-16 Biosense Webster, Inc. Epicardial mapping and ablation catheter
WO2010120847A1 (en) 2009-04-14 2010-10-21 Old Dominion University Research Foundation System and method for applying plasma sparks to tissue
US9566107B2 (en) 2009-04-22 2017-02-14 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and apparatus for radiofrequency ablation with increased depth and/or decreased volume of ablated tissue
CA2703347C (en) 2009-05-08 2016-10-04 Endosense Sa Method and apparatus for controlling lesion size in catheter-based ablation treatment
US8571647B2 (en) 2009-05-08 2013-10-29 Rhythmia Medical, Inc. Impedance based anatomy generation
US8103338B2 (en) 2009-05-08 2012-01-24 Rhythmia Medical, Inc. Impedance based anatomy generation
US8430875B2 (en) 2009-05-19 2013-04-30 Estech, Inc. (Endoscopic Technologies, Inc.) Magnetic navigation systems and methods
WO2010138919A2 (en) 2009-05-28 2010-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
WO2010144402A2 (en) 2009-06-08 2010-12-16 Surgivision, Inc. Mri-guided surgical systems with preset scan planes
GB2472216A (en) 2009-07-28 2011-02-02 Gyrus Medical Ltd Bipolar electrosurgical instrument with four electrodes
US20110028962A1 (en) 2009-07-31 2011-02-03 Randell Werneth Adjustable pulmonary vein ablation catheter
US9216055B2 (en) 2009-08-05 2015-12-22 Scr Inc. Systems, devices and methods for treating the heart with ablation
US9042969B2 (en) 2009-08-12 2015-05-26 Angel Medical Systems, Inc. Heart rate correction system and methods for the detection of cardiac events
US20110054487A1 (en) 2009-09-02 2011-03-03 Circulite, Inc. Coaxial transseptal guide-wire and needle assembly
US20150321021A1 (en) 2009-09-03 2015-11-12 The Johns Hopkins University Method and device for treating cardiac arrhythmias
US9642534B2 (en) 2009-09-11 2017-05-09 University Of Virginia Patent Foundation Systems and methods for determining location of an access needle in a subject
US20110098694A1 (en) 2009-10-28 2011-04-28 Ethicon Endo-Surgery, Inc. Methods and instruments for treating cardiac tissue through a natural orifice
US9861438B2 (en) 2009-12-11 2018-01-09 Biosense Webster (Israel), Ltd. Pre-formed curved ablation catheter
US8608735B2 (en) 2009-12-30 2013-12-17 Biosense Webster (Israel) Ltd. Catheter with arcuate end section
US9005198B2 (en) 2010-01-29 2015-04-14 Ethicon Endo-Surgery, Inc. Surgical instrument comprising an electrode
US20110190727A1 (en) 2010-02-02 2011-08-04 Boston Scientific Scimed, Inc. Intervascular catheter, system and method
US8556891B2 (en) 2010-03-03 2013-10-15 Medtronic Ablation Frontiers Llc Variable-output radiofrequency ablation power supply
US20120046570A1 (en) 2010-03-08 2012-02-23 Alpha Orthopaedics, Inc. Methods and devices for real time monitoring of collagen content and for altering collagen status
WO2011127211A2 (en) 2010-04-08 2011-10-13 The Regents Of The University Of California Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders
CA2796347A1 (en) 2010-04-13 2011-10-20 Sentreheart, Inc. Methods and devices for pericardial access
AU2011241103A1 (en) 2010-04-13 2012-11-08 Sentreheart, Inc. Methods and devices for treating atrial fibrillation
US9943363B2 (en) 2010-04-28 2018-04-17 Biosense Webster, Inc. Irrigated ablation catheter with improved fluid flow
US9510894B2 (en) 2010-04-28 2016-12-06 Biosense Webster (Israel) Ltd. Irrigated ablation catheter having irrigation ports with reduced hydraulic resistance
EP4257065A3 (en) 2010-05-05 2023-12-27 ElectroPhysiology Frontiers S.p.A. Anchored cardiac ablation catheter
US9924997B2 (en) 2010-05-05 2018-03-27 Ablacor Medical Corporation Anchored ablation catheter
US9655677B2 (en) 2010-05-12 2017-05-23 Shifamed Holdings, Llc Ablation catheters including a balloon and electrodes
RU2531439C2 (en) 2010-06-08 2014-10-20 Торэй Индастриз, Инк. Catheter for measuring electrical potential
ITRM20100314A1 (en) 2010-06-09 2011-12-10 Luca Viviana De CATHETER WITH REVERSIBLE STABILITY, FOR STABILIZATION DURING THE ABLATION TRANSCATETERE BY MEANS OF RADIO FREQUENCY.
JP5936610B2 (en) 2010-06-28 2016-06-22 コリブリ ハート バルブ エルエルシーColibri Heart Valve Llc Device for intracavity delivery of an intravascular injection device
US20120029512A1 (en) 2010-07-30 2012-02-02 Willard Martin R Balloon with surface electrodes and integral cooling for renal nerve ablation
WO2012013243A1 (en) 2010-07-30 2012-02-02 Umc Utrecht Holding B.V. Generator, combination of a generator and a catheter, and method for providing an electrical pulse
JP2012050538A (en) 2010-08-31 2012-03-15 Terumo Corp Ablation device
US9289606B2 (en) 2010-09-02 2016-03-22 St. Jude Medical, Atrial Fibrillation Division, Inc. System for electroporation therapy
US20120078320A1 (en) * 2010-09-29 2012-03-29 Medtronic, Inc. Prioritized programming of multi-electrode pacing leads
US20120089089A1 (en) 2010-10-12 2012-04-12 Ethicon Endo-Surgery, Inc. Methods of magnetically guiding and axially aligning distal ends of surgical devices
CN202478392U (en) 2010-10-20 2012-10-10 美敦力阿迪安卢森堡有限责任公司 Associated system of catheter device
EP2613723B1 (en) 2010-11-19 2017-10-25 St. Jude Medical Atrial Fibrillation Division Inc. Electrode catheter device with indifferent electrode for direct current tissue therapies
JP6046631B2 (en) 2010-11-19 2016-12-21 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Renal nerve detection and excision device
US20120158021A1 (en) 2010-12-19 2012-06-21 Mitralign, Inc. Steerable guide catheter having preformed curved shape
WO2012088149A2 (en) 2010-12-20 2012-06-28 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US9308041B2 (en) 2010-12-22 2016-04-12 Biosense Webster (Israel) Ltd. Lasso catheter with rotating ultrasound transducer
DE102010064101B4 (en) 2010-12-23 2017-02-23 Siemens Healthcare Gmbh Pair of endocardial and epicardial catheters and catheters
US20120303019A1 (en) 2010-12-25 2012-11-29 Xue Zhao Kind of cardiac ablation catheter with guide-wire
US9149327B2 (en) 2010-12-27 2015-10-06 St. Jude Medical Luxembourg Holding S.À.R.L. Prediction of atrial wall electrical reconnection based on contact force measured during RF ablation
EP3482708B1 (en) 2010-12-27 2021-03-10 St. Jude Medical International Holding S.à r.l. Prediction of atrial wall electrical reconnection based on contact force measured duing rf ablation
US9572620B2 (en) 2010-12-29 2017-02-21 Kyungmoo Ryu System and method for treating arrhythmias in the heart using information obtained from heart wall motion
US9044245B2 (en) 2011-01-05 2015-06-02 Medtronic Ablation Frontiers Llc Multipolarity epicardial radiofrequency ablation
US9095262B2 (en) 2011-01-05 2015-08-04 Mehdi Razavi Guided ablation devices, systems, and methods
US9002442B2 (en) 2011-01-13 2015-04-07 Rhythmia Medical, Inc. Beat alignment and selection for cardiac mapping
CA2764494A1 (en) 2011-01-21 2012-07-21 Kardium Inc. Enhanced medical device for use in bodily cavities, for example an atrium
US9480525B2 (en) 2011-01-21 2016-11-01 Kardium, Inc. High-density electrode-based medical device system
US9314620B2 (en) 2011-02-28 2016-04-19 Ethicon Endo-Surgery, Inc. Electrical ablation devices and methods
CA2842302C (en) 2011-03-08 2019-09-10 Todd J. Cohen Ablation catheter system with safety features
US9937002B2 (en) 2011-03-08 2018-04-10 Nexus Control Systems, Llc Ablation catheter system with safety features
CN103747756B (en) 2011-04-13 2016-12-07 维特罗纳斯有限公司 integrated ablation and mapping system
CN103718191B (en) 2011-05-02 2018-02-02 加利福尼亚大学董事会 Systems and methods for targeting cardiac rhythm disorders using shaping ablation
KR101248959B1 (en) 2011-05-12 2013-04-01 신경민 Electrode device having flexible tube for high frequency thermotherapy
US9072518B2 (en) 2011-05-31 2015-07-07 Atricure, Inc. High-voltage pulse ablation systems and methods
US20120310230A1 (en) 2011-06-01 2012-12-06 Angiodynamics, Inc. Coaxial dual function probe and method of use
US20120316557A1 (en) 2011-06-08 2012-12-13 Tyco Healthcare Group Lp Septoplasty Instrument
EP2823857B1 (en) 2011-06-15 2015-08-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Apparatus for terminating an atrial fibrillation of an atrium of a heart
US10506948B2 (en) 2011-07-05 2019-12-17 Cardioinsight Technologies, Inc. Localization for electrocardiographic mapping
WO2013013099A1 (en) 2011-07-19 2013-01-24 Adagio Medical, Inc. Methods and devices for the treatment of atrial fibrillation
US20130030430A1 (en) 2011-07-29 2013-01-31 Stewart Mark T Intracardiac tools and methods for delivery of electroporation therapies
EP2765940B1 (en) 2011-10-11 2015-08-26 Boston Scientific Scimed, Inc. Off-wall electrode device for nerve modulation
WO2013096199A1 (en) 2011-12-20 2013-06-27 Cardiac Pacemakers, Inc. Ectopic-triggered para-his stimulation
US8825130B2 (en) 2011-12-30 2014-09-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Electrode support structure assemblies
US9687289B2 (en) 2012-01-04 2017-06-27 Biosense Webster (Israel) Ltd. Contact assessment based on phase measurement
JP2015506234A (en) 2012-01-10 2015-03-02 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Electrophysiology system
US9414881B2 (en) 2012-02-08 2016-08-16 Angiodynamics, Inc. System and method for increasing a target zone for electrical ablation
US8808273B2 (en) 2012-02-10 2014-08-19 Biosense Webster (Israel) Ltd. Electrophysiology catheter with mechanical use limiter
US9095350B2 (en) 2012-05-01 2015-08-04 Medtronic Ablation Frontiers Llc Impedance detection of venous placement of multi-electrode catheters
WO2013165584A1 (en) 2012-05-04 2013-11-07 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for controlling delivery of ablation energy to tissue
US9017321B2 (en) 2012-05-21 2015-04-28 Kardium, Inc. Systems and methods for activating transducers
US9554847B2 (en) 2012-07-02 2017-01-31 Biosense Webster (Israel) Ltd. Real time assessment of ablation from electrocardiogram signals
US9101374B1 (en) 2012-08-07 2015-08-11 David Harris Hoch Method for guiding an ablation catheter based on real time intracardiac electrical signals and apparatus for performing the method
CA2881462C (en) 2012-08-09 2020-07-14 University Of Iowa Research Foundation Catheters, catheter systems, and methods for puncturing through a tissue structure
US9277957B2 (en) 2012-08-15 2016-03-08 Ethicon Endo-Surgery, Inc. Electrosurgical devices and methods
US20140052216A1 (en) 2012-08-15 2014-02-20 Ethicon Endo-Surgery, Inc. Methods for promoting wound healing
US9801681B2 (en) 2012-08-17 2017-10-31 Medtronic Ablation Frontiers Llc Catheters and methods for intracardiac electrical mapping
US9168004B2 (en) 2012-08-20 2015-10-27 Biosense Webster (Israel) Ltd. Machine learning in determining catheter electrode contact
WO2014031800A1 (en) 2012-08-22 2014-02-27 Energize Medical Llc Therapeutic energy systems
EP2890292B1 (en) 2012-08-31 2021-01-13 Acutus Medical, Inc. Catheter system for the heart
JP2014054430A (en) 2012-09-13 2014-03-27 Nippon Koden Corp Catheter
US11096741B2 (en) 2012-10-10 2021-08-24 Biosense Webster (Israel) Ltd. Ablation power control based on contact force
US9827036B2 (en) 2012-11-13 2017-11-28 Pulnovo Medical (Wuxi) Co., Ltd. Multi-pole synchronous pulmonary artery radiofrequency ablation catheter
US9757185B2 (en) 2012-11-29 2017-09-12 Gyrus Acmi, Inc. Quadripolar forceps
WO2014089373A1 (en) 2012-12-05 2014-06-12 University Of Rochester Catheter with integrated transeptal puncture needle
US9023036B2 (en) 2012-12-07 2015-05-05 Biosense Webster (Israel) Ltd. Lasso catheter with tip electrode
US9078667B2 (en) 2012-12-11 2015-07-14 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter having reduced force concentration at tissue contact site
US9474850B2 (en) 2012-12-11 2016-10-25 Biosense Webster (Israel) Ltd. Lasso catheter with guide wire
WO2014100579A1 (en) 2012-12-21 2014-06-26 David Anderson Functional gain measurement technique and representation
US9204820B2 (en) 2012-12-31 2015-12-08 Biosense Webster (Israel) Ltd. Catheter with combined position and pressure sensing structures
US10537286B2 (en) 2013-01-08 2020-01-21 Biosense Webster (Israel) Ltd. Catheter with multiple spines of different lengths arranged in one or more distal assemblies
WO2014118734A2 (en) 2013-01-31 2014-08-07 David Prutchi Unipolar and/or bipolar ablation catheter
US9031642B2 (en) 2013-02-21 2015-05-12 Medtronic, Inc. Methods for simultaneous cardiac substrate mapping using spatial correlation maps between neighboring unipolar electrograms
US9474486B2 (en) 2013-03-08 2016-10-25 St. Jude Medical, Atrial Fibrillation Division, Inc. Basket for a multi-electrode array catheter
US9519021B2 (en) 2013-03-11 2016-12-13 Covidien Lp Systems and methods for detecting abnormalities within a circuit of an electrosurgical generator
US9486272B2 (en) 2013-03-12 2016-11-08 Biosense Webster (Israel) Ltd. Force feedback device and method for catheters
CN105142558A (en) 2013-03-15 2015-12-09 美敦力阿迪安卢森堡有限公司 Treatment device with electrode contact surface configured for enhancing uniformity of electrical energy distribution and associated devices and methods
US9345540B2 (en) 2013-03-15 2016-05-24 Medtronic Ablation Frontiers Llc Contact specific RF therapy balloon
SG11201507936UA (en) 2013-03-27 2015-10-29 Autonomix Medical Inc Neurological traffic and receptor evaluation and modification: systems and methods
KR20150140760A (en) 2013-04-08 2015-12-16 아파마 메디칼, 인크. Cardiac ablation catheters and methods of use thereof
US10575743B2 (en) 2013-04-11 2020-03-03 Biosense Webster (Israel) Ltd. High electrode density basket catheter
US20160113709A1 (en) 2013-06-05 2016-04-28 Tel Hashomer Medical Research Infrastructure And Services Ltd Myocardial ablation by irreversible electroporation
EP3030185B1 (en) 2013-08-06 2023-05-10 Memorial Sloan Kettering Cancer Center System and computer-accessible medium for in-vivo tissue ablation and/or damage
JP6280652B2 (en) 2013-08-29 2018-02-14 ボストン サイエンティフィック ニューロモデュレイション コーポレイション System and method for adjusting compliance voltage of neuromodulation device
US9931046B2 (en) 2013-10-25 2018-04-03 Ablative Solutions, Inc. Intravascular catheter with peri-vascular nerve activity sensors
WO2015066322A1 (en) 2013-11-01 2015-05-07 Boston Scientific Scimed, Inc. Cardiac mapping using latency interpolation
EP3071137A1 (en) 2013-11-20 2016-09-28 Boston Scientific Scimed, Inc. Ablation medical devices and methods for making and using ablation medical devices
US20150173828A1 (en) 2013-12-23 2015-06-25 Boaz Avitall Small loop ablation catheter
US20160324564A1 (en) 2013-12-27 2016-11-10 Empire Technology Development Llc Devices and techniques for ablative treatment
EP3091921B1 (en) 2014-01-06 2019-06-19 Farapulse, Inc. Apparatus for renal denervation ablation
EP3091925A1 (en) 2014-01-06 2016-11-16 Iowa Approach Inc. Devices and methods for delivering therapeutic electrical impulses
US20170172654A1 (en) 2014-02-11 2017-06-22 St. Jude Medical, Cardiology Division, Inc. Ablation catheter and associated methods
AU2015218223B2 (en) 2014-02-17 2019-05-16 Children's National Medical Center Delivery tool and method for devices in the pericardial space
JP6393768B2 (en) 2014-02-25 2018-09-19 セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド System and method for local electrophysiological representation of cardiac matrix characteristics using a multi-electrode catheter
GEP20197025B (en) 2014-03-20 2019-10-10 S P A Atricath Ablation catheter and ablation apparatus
WO2015143327A1 (en) 2014-03-21 2015-09-24 Mayo Foundation For Medical Education And Research Multi-electrode epicardial pacing
US9956035B2 (en) 2014-03-27 2018-05-01 Biosense Webster (Israel) Ltd. Temperature measurement in catheter
US20150289923A1 (en) 2014-04-14 2015-10-15 Virginia Tech Intellectual Properties, Inc. Treatment planning for electrical-energy based therapies based on cell characteristics
US10342606B2 (en) 2014-05-06 2019-07-09 Cosman Instruments, Llc Electrosurgical generator
EP3495018B1 (en) * 2014-05-07 2023-09-06 Farapulse, Inc. Apparatus for selective tissue ablation
WO2015175944A1 (en) 2014-05-16 2015-11-19 Gary Long Methods and apparatus for multi-catheter tissue ablation
US9848795B2 (en) 2014-06-04 2017-12-26 Boston Scientific Scimed Inc. Electrode assembly
WO2015192018A1 (en) 2014-06-12 2015-12-17 Iowa Approach Inc. Method and apparatus for rapid and selective tissue ablation with cooling
EP3154463B1 (en) 2014-06-12 2019-03-27 Farapulse, Inc. Apparatus for rapid and selective transurethral tissue ablation
US12114911B2 (en) 2014-08-28 2024-10-15 Angiodynamics, Inc. System and method for ablating a tissue site by electroporation with real-time pulse monitoring
WO2016059027A1 (en) 2014-10-13 2016-04-21 Dr Philippe Debruyne Bvba Limited ablation for the treatment of sick sinus syndrome and other inappropriate sinus bradycardias
JP2017529169A (en) 2014-10-13 2017-10-05 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Tissue diagnosis and treatment using mini-electrodes
EP3206613B1 (en) * 2014-10-14 2019-07-03 Farapulse, Inc. Apparatus for rapid and safe pulmonary vein cardiac ablation
US10231778B2 (en) 2014-10-20 2019-03-19 Biosense Webster (Israel) Ltd. Methods for contemporaneous assessment of renal denervation
WO2016065337A1 (en) 2014-10-24 2016-04-28 Boston Scientific Scimed Inc. Medical devices with a flexible electrode assembly coupled to an ablation tip
JP6725178B2 (en) 2014-11-19 2020-07-15 エピックス セラピューティクス,インコーポレイテッド Ablation apparatus, systems and methods using high resolution electrode assemblies
CA2969129A1 (en) 2014-12-03 2016-06-09 Metavention, Inc. Systems and methods for modulating nerves or other tissue
US10271893B2 (en) 2014-12-15 2019-04-30 Medtronic Ablation Frontiers Llc Timed energy delivery
US9743854B2 (en) 2014-12-18 2017-08-29 Boston Scientific Scimed, Inc. Real-time morphology analysis for lesion assessment
JP2018501874A (en) 2014-12-31 2018-01-25 セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド Filter circuit for electrophysiology system
US9782099B2 (en) 2014-12-31 2017-10-10 Biosense Webster (Israel) Ltd. Basket catheter with improved spine flexibility
WO2016183337A2 (en) 2015-05-12 2016-11-17 National University Of Ireland Galway Devices for therapeutic nasal neuromodulation and associated methods and systems
WO2016180934A1 (en) 2015-05-12 2016-11-17 Umc Utrecht Holding B.V. Asymmetric balanced waveform for ac cardiac irreversible electroporation
WO2016201264A1 (en) 2015-06-11 2016-12-15 Massachusetts Institute Of Technology Methods for inducing electroporation and tissue ablation
US9949656B2 (en) 2015-06-29 2018-04-24 Biosense Webster (Israel) Ltd. Catheter with stacked spine electrode assembly
US10583294B2 (en) 2015-07-02 2020-03-10 Dirk De Ridder Methods and apparatus for sensing cross-frequency coupling and neuromodulation
CN107921258B (en) 2015-08-06 2021-09-07 美敦力公司 Cardiac pulse field ablation
US9931487B2 (en) 2015-08-06 2018-04-03 Boston Scientific Scimed, Inc. Bidirectional steering control apparatus for a catheter
US20170071543A1 (en) 2015-09-14 2017-03-16 Biosense Webster (Israel) Ltd. Convertible basket catheter
CN108472481A (en) 2015-10-06 2018-08-31 哈尔西恩医疗有限公司 Aortorenal ganglions detects
US20170105793A1 (en) 2015-10-15 2017-04-20 Boston Scientific Scimed, Inc. Energy delivery devices and related methods of use
JP6785301B2 (en) 2015-11-04 2020-11-18 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical devices and related methods
CA3006427A1 (en) 2015-12-01 2017-06-08 Symap Medical (Suzhou), Ltd System and method for mapping functional nerves innervating wall of arteries,3-d mapping and catheters for same
US20170189097A1 (en) 2016-01-05 2017-07-06 Iowa Approach Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
EP3399933B1 (en) 2016-01-05 2021-09-01 Farapulse, Inc. Systems for delivery of pulsed electric field ablative energy to endocardial tissue
EP3399931B1 (en) 2016-01-05 2022-04-06 Farapulse, Inc. System for delivery of ablative energy to tissue
US10130423B1 (en) 2017-07-06 2018-11-20 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10660702B2 (en) 2016-01-05 2020-05-26 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10172673B2 (en) 2016-01-05 2019-01-08 Farapulse, Inc. Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10548665B2 (en) 2016-02-29 2020-02-04 Pulse Biosciences, Inc. High-voltage analog circuit pulser with feedback control
US10874451B2 (en) 2016-02-29 2020-12-29 Pulse Biosciences, Inc. High-voltage analog circuit pulser and pulse generator discharge circuit
WO2017192510A2 (en) 2016-05-02 2017-11-09 Affera, Inc. Pulsed radiofrequency ablation
EP3471631A4 (en) 2016-06-16 2020-03-04 Farapulse, Inc. GUIDE WIRE DISTRIBUTION SYSTEMS, APPARATUSES AND METHODS
WO2018005511A1 (en) 2016-06-27 2018-01-04 Gala Therapeutics, Inc. Generator and a catheter with an electrode and a method for treating a lung passageway
AU2017357869B2 (en) 2016-11-11 2023-06-15 National University Of Ireland, Galway Devices, systems, and methods for specializing, monitoring, and/or evaluating therapeutic nasal neuromodulation
EP3554406A1 (en) 2016-12-19 2019-10-23 Boston Scientific Scimed Inc. Distally-facing electrode array with longitudinally mounted splines
US20180184982A1 (en) 2017-01-05 2018-07-05 Biosense Webster (Israel) Ltd. Hybrid balloon basket catheter
US10912609B2 (en) 2017-01-06 2021-02-09 St. Jude Medical, Cardiology Division, Inc. Pulmonary vein isolation balloon catheter
US11432871B2 (en) 2017-04-10 2022-09-06 St. Jude Medical, Cardiology Division, Inc. Electroporation system and method of preconditioning tissue for electroporation therapy
CN110461262B (en) 2017-04-10 2023-01-06 圣犹达医疗用品心脏病学部门有限公司 Electroporation system and method of stimulating catheter
EP4005500A1 (en) 2017-04-20 2022-06-01 Medtronic, Inc. Stabilization of a transseptal delivery device
US9987081B1 (en) 2017-04-27 2018-06-05 Iowa Approach, Inc. Systems, devices, and methods for signal generation
US10617867B2 (en) 2017-04-28 2020-04-14 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
EP3634284A1 (en) 2017-06-06 2020-04-15 Cardiac Pacemakers, Inc. Ablation delivery using a catheter having a semi-permeable inflatable balloon structure
US20180360534A1 (en) 2017-06-19 2018-12-20 St. Jude Medical, Cardiology Division, Inc. Apparatuses and methods for high-density sensing and ablation during a medical procedure
US11633121B2 (en) 2017-08-04 2023-04-25 Medtronic, Inc. Ablation check pulse routine and integration for electroporation
US10850095B2 (en) 2017-08-08 2020-12-01 Pulse Biosciences, Inc. Treatment of tissue by the application of energy
EP4279004B1 (en) 2017-10-26 2025-08-13 Boston Scientific Scimed, Inc. Use of electromagnetic fields in ire device delivery and therapy monitoring
EP3723845B1 (en) 2017-12-11 2025-01-22 Mayo Foundation for Medical Education and Research Systems for electroporation
JP7106644B2 (en) 2017-12-19 2022-07-26 セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド A method for assessing contact between electrodes and tissue using complex impedance measurements
DK3731772T3 (en) 2017-12-26 2024-06-03 Galvanize Therapeutics Inc SYSTEMS FOR THE TREATMENT OF DISEASE STATES AND DISORDERS
US20190336198A1 (en) 2018-05-03 2019-11-07 Farapulse, Inc. Systems, devices, and methods for ablation using surgical clamps
WO2019217433A1 (en) 2018-05-07 2019-11-14 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
EP3578124A1 (en) 2018-06-05 2019-12-11 National University of Ireland Galway Electrophysiology apparatus

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200104A (en) * 1977-11-17 1980-04-29 Valleylab, Inc. Contact area measurement apparatus for use in electrosurgery
US5242441A (en) * 1992-02-24 1993-09-07 Boaz Avitall Deflectable catheter with rotatable tip electrode
US20040087939A1 (en) * 1993-05-10 2004-05-06 Arthrocare Corporation Methods for electrosurgical tissue treatment between spaced apart electrodes
US5578040A (en) * 1994-06-14 1996-11-26 Smith; Albert C. Ocular repair system and apparatus
US5836874A (en) * 1996-04-08 1998-11-17 Ep Technologies, Inc. Multi-function electrode structures for electrically analyzing and heating body tissue
US5863291A (en) * 1996-04-08 1999-01-26 Cardima, Inc. Linear ablation assembly
US6805128B1 (en) * 1996-10-22 2004-10-19 Epicor Medical, Inc. Apparatus and method for ablating tissue
US20030130711A1 (en) * 2001-09-28 2003-07-10 Pearson Robert M. Impedance controlled tissue ablation apparatus and method
US20060293731A1 (en) * 2005-06-24 2006-12-28 Boris Rubinsky Methods and systems for treating tumors using electroporation
US20090062788A1 (en) * 2007-08-31 2009-03-05 Long Gary L Electrical ablation surgical instruments
US20090076500A1 (en) * 2007-09-14 2009-03-19 Lazure Technologies, Llc Multi-tine probe and treatment by activation of opposing tines
US20090138009A1 (en) * 2007-11-05 2009-05-28 Viswanathan Raju R Magnetically guided energy delivery apparatus
US20110130708A1 (en) * 2009-05-13 2011-06-02 Minnow Medical, Inc. Directional Delivery of Energy and Bioactives
US20120095459A1 (en) * 2010-10-13 2012-04-19 Peter Callas System and Method for Electrically Ablating Tissue of a Patient

Cited By (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10820941B2 (en) 2006-06-28 2020-11-03 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US11389231B2 (en) 2006-06-28 2022-07-19 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US11389232B2 (en) 2006-06-28 2022-07-19 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US11399890B2 (en) 2006-06-28 2022-08-02 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US10828094B2 (en) 2006-06-28 2020-11-10 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US10828093B2 (en) 2006-06-28 2020-11-10 Kardium Inc. Apparatus and method for intra-cardiac mapping and ablation
US10828098B2 (en) 2007-11-16 2020-11-10 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11076913B2 (en) 2007-11-16 2021-08-03 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US10828097B2 (en) 2007-11-16 2020-11-10 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US10499986B2 (en) 2007-11-16 2019-12-10 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US10828095B2 (en) 2007-11-16 2020-11-10 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US10828096B2 (en) 2007-11-16 2020-11-10 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11304751B2 (en) 2007-11-16 2022-04-19 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11331141B2 (en) 2007-11-16 2022-05-17 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11432874B2 (en) 2007-11-16 2022-09-06 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11413091B2 (en) 2007-11-16 2022-08-16 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11801091B2 (en) 2007-11-16 2023-10-31 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11633231B2 (en) 2007-11-16 2023-04-25 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11751940B2 (en) 2007-11-16 2023-09-12 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
US11690684B2 (en) 2012-05-21 2023-07-04 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10568576B2 (en) 2012-05-21 2020-02-25 Kardium Inc. Systems and methods for activating transducers
US11633238B2 (en) 2012-05-21 2023-04-25 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10918446B2 (en) 2012-05-21 2021-02-16 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US12376796B2 (en) 2012-05-21 2025-08-05 Kardium Inc. Systems and methods for activating transducers
US11805974B2 (en) 2012-05-21 2023-11-07 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US11589821B2 (en) 2012-05-21 2023-02-28 Kardium Inc. Systems and methods for activating transducers
US11672485B2 (en) 2012-05-21 2023-06-13 Kardium Inc. Systems and methods for activating transducers
US12376795B2 (en) 2012-05-21 2025-08-05 Kardium Inc. Systems and methods for activating transducers
US11154248B2 (en) 2012-05-21 2021-10-26 Kardium Inc. Systems and methods for activating transducers
US12324636B2 (en) 2012-05-21 2025-06-10 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10827977B2 (en) 2012-05-21 2020-11-10 Kardium Inc. Systems and methods for activating transducers
US12226172B2 (en) 2012-05-21 2025-02-18 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10470826B2 (en) 2012-05-21 2019-11-12 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US11426573B2 (en) 2012-08-09 2022-08-30 University Of Iowa Research Foundation Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region
US10517672B2 (en) 2014-01-06 2019-12-31 Farapulse, Inc. Apparatus and methods for renal denervation ablation
US11589919B2 (en) 2014-01-06 2023-02-28 Boston Scientific Scimed, Inc. Apparatus and methods for renal denervation ablation
US12390272B2 (en) 2014-05-07 2025-08-19 Boston Scientific Scimed, Inc. Methods and apparatus for selective tissue ablation
US11259869B2 (en) 2014-05-07 2022-03-01 Farapulse, Inc. Methods and apparatus for selective tissue ablation
US12408979B2 (en) 2014-05-07 2025-09-09 Boston Scientific Scimed, Inc. Methods and apparatus for selective tissue ablation
US12137968B2 (en) 2014-05-16 2024-11-12 Boston Scientific Scimed, Inc. Methods and apparatus for multi-catheter tissue ablation
US10624693B2 (en) 2014-06-12 2020-04-21 Farapulse, Inc. Method and apparatus for rapid and selective tissue ablation with cooling
US11622803B2 (en) 2014-06-12 2023-04-11 Boston Scientific Scimed, Inc. Method and apparatus for rapid and selective tissue ablation with cooling
US10433906B2 (en) 2014-06-12 2019-10-08 Farapulse, Inc. Method and apparatus for rapid and selective transurethral tissue ablation
US11241282B2 (en) 2014-06-12 2022-02-08 Boston Scientific Scimed, Inc. Method and apparatus for rapid and selective transurethral tissue ablation
US12161397B2 (en) 2014-06-12 2024-12-10 Boston Scientific Scimed, Inc. Method and apparatus for rapid and selective transurethral tissue ablation
US10835314B2 (en) 2014-10-14 2020-11-17 Farapulse, Inc. Method and apparatus for rapid and safe pulmonary vein cardiac ablation
US12295648B2 (en) 2014-10-14 2025-05-13 Boston Scientific Scimed, Inc. Method and apparatus for rapid and safe pulmonary vein cardiac ablation
US12133745B2 (en) 2014-11-17 2024-11-05 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10758191B2 (en) 2014-11-17 2020-09-01 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US11026637B2 (en) 2014-11-17 2021-06-08 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US11026638B2 (en) 2014-11-17 2021-06-08 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10368936B2 (en) 2014-11-17 2019-08-06 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10722184B2 (en) 2014-11-17 2020-07-28 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US12383208B2 (en) 2014-11-17 2025-08-12 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US10751006B2 (en) 2014-11-17 2020-08-25 Kardium Inc. Systems and methods for selecting, activating, or selecting and activating transducers
US12207866B2 (en) 2015-08-06 2025-01-28 Medtronic, Inc. Cardiac pulsed field ablation
US12201353B2 (en) 2015-08-06 2025-01-21 Medtronic, Inc. Cardiac pulsed field ablation
US12150700B2 (en) 2015-08-06 2024-11-26 Medtronic, Inc. Cardiac pulsed field ablation
US12150701B2 (en) 2015-08-06 2024-11-26 Medtronic, Inc. Cardiac pulsed field ablation
US10433908B2 (en) 2016-01-05 2019-10-08 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10660702B2 (en) 2016-01-05 2020-05-26 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10512779B2 (en) 2016-01-05 2019-12-24 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US11589921B2 (en) 2016-01-05 2023-02-28 Boston Scientific Scimed, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10172673B2 (en) 2016-01-05 2019-01-08 Farapulse, Inc. Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10709891B2 (en) 2016-01-05 2020-07-14 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10842561B2 (en) 2016-01-05 2020-11-24 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10322286B2 (en) 2016-01-05 2019-06-18 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US11020179B2 (en) 2016-01-05 2021-06-01 Farapulse, Inc. Systems, devices, and methods for focal ablation
US12144541B2 (en) 2016-01-05 2024-11-19 Boston Scientific Scimed, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10507302B2 (en) 2016-06-16 2019-12-17 Farapulse, Inc. Systems, apparatuses, and methods for guide wire delivery
US12246143B2 (en) 2016-06-16 2025-03-11 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for guide wire delivery
US12403305B2 (en) 2016-06-27 2025-09-02 Galvanize Therapeutics, Inc. Immunostimulation in the treatment of viral infection
US12349967B2 (en) 2016-06-27 2025-07-08 Galvanize Therapeutics, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US10702337B2 (en) 2016-06-27 2020-07-07 Galary, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US11369433B2 (en) 2016-06-27 2022-06-28 Galvanize Therapeutics, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US10939958B2 (en) 2016-06-27 2021-03-09 Galary, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US11357978B2 (en) 2017-04-27 2022-06-14 Boston Scientific Scimed, Inc. Systems, devices, and methods for signal generation
US12121720B2 (en) 2017-04-27 2024-10-22 Boston Scientific Scimed, Inc. Systems, devices, and methods for signal generation
US9987081B1 (en) 2017-04-27 2018-06-05 Iowa Approach, Inc. Systems, devices, and methods for signal generation
US10016232B1 (en) 2017-04-27 2018-07-10 Iowa Approach, Inc. Systems, devices, and methods for signal generation
US10617867B2 (en) 2017-04-28 2020-04-14 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
US11833350B2 (en) 2017-04-28 2023-12-05 Boston Scientific Scimed, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
US10617467B2 (en) 2017-07-06 2020-04-14 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10130423B1 (en) 2017-07-06 2018-11-20 Farapulse, Inc. Systems, devices, and methods for focal ablation
US12150698B2 (en) 2017-09-12 2024-11-26 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for ventricular focal ablation
US10893905B2 (en) 2017-09-12 2021-01-19 Farapulse, Inc. Systems, apparatuses, and methods for ventricular focal ablation
US12295637B2 (en) 2018-02-08 2025-05-13 Boston Scientific Scimed, Inc. Method and apparatus for controlled delivery of pulsed electric field ablative energy to tissue
US12042208B2 (en) 2018-05-03 2024-07-23 Boston Scientific Scimed, Inc. Systems, devices, and methods for ablation using surgical clamps
US10512505B2 (en) 2018-05-07 2019-12-24 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US11033236B2 (en) 2018-05-07 2021-06-15 Farapulse, Inc. Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation
US11020180B2 (en) 2018-05-07 2021-06-01 Farapulse, Inc. Epicardial ablation catheter
US12257080B2 (en) 2018-05-07 2025-03-25 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation
US10709502B2 (en) 2018-05-07 2020-07-14 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US12274491B2 (en) 2018-05-07 2025-04-15 Boston Scientific Scimed, Inc. Epicardial ablation catheter
US10687892B2 (en) 2018-09-20 2020-06-23 Farapulse, Inc. Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US12318130B2 (en) 2018-09-20 2025-06-03 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10688305B1 (en) 2019-09-17 2020-06-23 Farapulse, Inc. Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation
US10625080B1 (en) 2019-09-17 2020-04-21 Farapulse, Inc. Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation
US11738200B2 (en) 2019-09-17 2023-08-29 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation
US11497541B2 (en) 2019-11-20 2022-11-15 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US11065047B2 (en) 2019-11-20 2021-07-20 Farapulse, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US11684408B2 (en) 2019-11-20 2023-06-27 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US11931090B2 (en) 2019-11-20 2024-03-19 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US12349953B2 (en) 2019-11-20 2025-07-08 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US10842572B1 (en) 2019-11-25 2020-11-24 Farapulse, Inc. Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines
US12268437B2 (en) 2020-07-24 2025-04-08 Boston Scientific Scimed, Inc. Electric field application for single shot cardiac ablation by irreversible electroporation
US12310652B2 (en) 2020-07-24 2025-05-27 Boston Scientific Scimed, Inc. Hybrid electroporation ablation catheter
US12349964B2 (en) 2020-09-30 2025-07-08 Boston Scientific Scimed, Inc. Pretreatment waveform for irreversible electroporation
US12343071B2 (en) 2021-01-27 2025-07-01 Boston Scientific Scimed, Inc Voltage controlled pulse sequences for irreversible electroporation ablations

Also Published As

Publication number Publication date
US20220000547A1 (en) 2022-01-06
US20170065340A1 (en) 2017-03-09
WO2015175944A1 (en) 2015-11-19
US12137968B2 (en) 2024-11-12
US20250064511A1 (en) 2025-02-27
EP3142584A1 (en) 2017-03-22

Similar Documents

Publication Publication Date Title
US12137968B2 (en) Methods and apparatus for multi-catheter tissue ablation
US12295648B2 (en) Method and apparatus for rapid and safe pulmonary vein cardiac ablation
US12408979B2 (en) Methods and apparatus for selective tissue ablation
JP7483628B2 (en) Systems, devices and methods for ablation using surgical clamps - Patents.com
CN111227926B (en) Pulser for irreversible electroporation
EP3831442A1 (en) Using reversible electroporation on cardiac tissue
JP2024081699A (en) Systems, devices and methods for localized ablation - Patents.com
JP2021087779A (en) Pulse generator for irreversible electroporation
JP2022013664A (en) Temperature control for ire
JP2022162997A (en) Pulse generator for irreversible electroporation with switchable pulse application

Legal Events

Date Code Title Description
AS Assignment

Owner name: IOWA APPROACH, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GLL, LLC;LONG, GARY L.;REEL/FRAME:044152/0930

Effective date: 20150909

AS Assignment

Owner name: FARAPULSE, INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:IOWA APPROACH, INC.;REEL/FRAME:047763/0221

Effective date: 20180531

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MASSACHUSETTS

Free format text: SECURITY INTEREST;ASSIGNOR:FARAPULSE, INC.;REEL/FRAME:053596/0364

Effective date: 20200821

STCV Information on status: appeal procedure

Free format text: NOTICE OF APPEAL FILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FARAPULSE, INC.;REEL/FRAME:060802/0286

Effective date: 20210806